Institutes
Refine
Year of publication
Document Type
- Doctoral Thesis (306)
- Article (278)
- Preprint (38)
- Contribution to a Periodical (25)
- Book (17)
- Report (2)
Language
- English (513)
- German (152)
- Multiple languages (1)
Has Fulltext
- yes (666)
Is part of the Bibliography
- no (666)
Keywords
- RNA (12)
- SARS-CoV-2 (10)
- NMR spectroscopy (9)
- inflammation (9)
- photochemistry (9)
- NMR (8)
- Biochemistry (7)
- Cell biology (7)
- E2 enzyme (6)
- TRACT (6)
Institute
- Biochemie, Chemie und Pharmazie (666)
- Präsidium (42)
- Medizin (35)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (30)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (30)
- Biowissenschaften (23)
- MPI für Biophysik (15)
- Physik (12)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (5)
- Geowissenschaften / Geographie (4)
B-cell acute lymphoblastic leukaemia (B-ALL) is characterized by the overproduction of lymphoblasts in the bone marrow (BM), and it is the most common cancer in children while being comparatively uncommon in adults. On the other hand, in chronic myeloid leukaemia (CML), 70% of cases are found in patients older than 50 years, making it uncommon in children. All CML cases and up to 3% of paediatric B- ALL (and 25% of adult B-ALL) cases are due to fusion gene BCR-ABL1, which gives rise to the cytoplasmatic, constitutively active oncoprotein, tyrosine kinase BCR-ABL1 through a reciprocal translocation between chromosomes 9 and 22. The constitutively active BCR-ABL tyrosine kinase leads to deregulation of different signal transduction pathways such as cell growth, proliferation and cell survival. The role of the bone marrow microenvironment (BMM) can mediate disease initiation (only in mice), progression, therapy resistance, and relapse, as has been increasingly recognized over the last two decades. In general, the BMM is a very complex arrangement of various cell types such as osteoblasts, osteoclasts, endothelial cells, adipocytes, mesenchymal stromal cells, macrophages and several others. In addition, the BMM is composed of multiple chemical and mechanical factors and extra cellular matrix (ECM) proteins which contribute to the BMM’s features influencing leukaemia behaviour. Considering the incidence of B-ALL and CML in children and in adults respectively, we hypothesized that the young and/or an aged BMM might also play a previously unrecognized role in the aggressiveness of B-ALL and CML. We proposed that BM, transduced with BCR-ABL1-expressing retrovirus in the murine transduction/transplantation model of B-ALL, transplanted into young versus old recipient mice would lead to a more aggressive disease in young mice, and similarly CML would be more aggressive in old recipient mice. In close recapitulation with the human incidence, induction of CML led to a significantly shorted survival in old recipient mice. On the other hand, induction of B-ALL showed a shortened survival in young compared to old syngeneic mice, as well as in a xenotransplantation model. Among the highly heterogenous composition of the BMM, we implicate young BM macrophages as a supportive niche for B-ALL cells. The results were found to be mostly due to potential soluble factors differentially secreted from young and old macrophages. Therefore, we hypothesized that the chemokine CXCL13, which has been demonstrated to play a role in B cell migration and act as a diagnostic marker in the cerebrospinal fluid of patients with neuroborreliosis, might be responsible for the observed phenotype. CXCL13 was found to be more highly expressed in healthy and leukaemic young mice as well as in conditioned medium of young macrophages. Using a variety of in vitro experiments, CXCL13 showed to significantly increase the proliferation and the migration of leukaemia cells when exposed to young macrophages, and the phenotype was rescued while using a CXCL13 neutralizing antibody. The CXCL13 role was also confirmed in vivo, since macrophage ablation led to a prolongation of survival in young mice and a reduction of CXCL13 levels. The use of an additional mouse model, leukaemia cells with CXCR5 deficiency, led to a significant prolongation of survival of young mice, confirming the importance of the CXCL13-CXCR5 axis in B-ALL. In line with our murine results, we found that human macrophages and CXCL13 levels were higher in pediatric B-ALL patients than in adults. Consistent with our murine data, the expression level of CXCR5 may act as a prognostic marker in B-ALL, as well as a predictive marker for central nervous system relapse in human B-ALL. The overall findings show that a young BMM, and in particular macrophages, influences B-ALL progression. We specifically identified CXCL13, secreted by young macrophages, as a promoter of proliferation of B-ALL cells, influencing survival in B-ALL via CXCR5. The CXCR5-CXCL13 axis may be relevant in human B-ALL, and higher CXCR5 expression in human B-ALL may act as a predictive marker.
Double reduction of the THF adduct of 9H-9-borafluorene (1⋅THF) with excess alkali metal affords the dianion salts M2[1] in essentially quantitative yields (M=Li–K). Even though the added charge is stabilized through π delocalization, [1]2− acts as a formal boron nucleophile toward organoboron (1⋅THF) and tetrel halide electrophiles (MeCl, Et3SiCl, Me3SnCl) to form B−B/C/Si/Sn bonds. The substrate dependence of open-shell versus closed-shell pathways has been investigated.
5-lipoxygenase (5-LO), the key enzyme in leukotriene biosynthesis, is expressed in a tissue- and cell differentiation-specific manner. The 5-LO core promoter required for basal promoter activity has a unique (G+C)-rich sequence that contains five tandem Sp1 consensus sequences. The mechanisms involved in the regulation of cell type-specific 5-LO expression are unknown. Here we show that 5-LO expression is regulated by DNA methylation. Treatment of the 5-LO-negative cell lines U937 and HL-60TB with the demethylating agent 5-aza-2'-deoxycytidine (AdC) up-regulated expression of 5-LO primary transcripts and mature mRNA in a similar fashion, indicating that AdC stimulates 5-LO gene transcription. Analysis of the methylation status of the 5-LO promoter revealed that the core promoter region was methylated in U937 and HL-60TB cells, whereas it was unmethylated in the 5-LO-positive parent HL-60 cell line. Reporter gene assays with 5-LO promoter constructs gave up to 68- and 655-fold repression of 5-LO promoter activity in HeLa and Mono Mac 6 cells by methylation. 1,25-dihydroxyvitamin D(3) and transforming growth factor-beta (TGFbeta), potent inducers of the 5-LO pathway in myeloid cell lines, increased 5-LO RNA expression in HL-60TB and U937 cells, but co-treatment with AdC was required to achieve 5-LO expression levels in HL-60TB cells that were comparable with wild-type HL-60 cells. In reporter gene assays, 1,25-dihydroxyvitamin D(3) and TGFbeta were unable to induce promoter activity when the 5-LO promoter constructs were methylated, which suggests that 5-LO promoter demethylation is a prerequisite for the high level induction of 5-LO gene expression by 1,25-dihydroxyvitamin D(3) and TGFbeta and that the effects of both agents on 5-LO mRNA expression are not related to DNA methylation.
Autophagy is a highly conserved catabolic process through which defective or otherwise harmful cellular components are targeted for degradation via the lysosomal route. Regulatory pathways, involving post-translational modifications such as phosphorylation, play a critical role in controlling this tightly orchestrated process. Here, we demonstrate that TBK1 regulates autophagy by phosphorylating autophagy modifiers LC3C and GABARAP-L2 on surface-exposed serine residues (LC3C S93 and S96; GABARAP-L2 S87 and S88). This phosphorylation event impedes their binding to the processing enzyme ATG4 by destabilizing the complex. Phosphorylated LC3C/GABARAP-L2 cannot be removed from liposomes by ATG4 and are thus protected from ATG4-mediated premature removal from nascent autophagosomes. This ensures a steady coat of lipidated LC3C/GABARAP-L2 throughout the early steps in autophagosome formation and aids in maintaining a unidirectional flow of the autophagosome to the lysosome. Taken together, we present a new regulatory mechanism of autophagy, which influences the conjugation and de-conjugation of LC3C and GABARAP-L2 to autophagosomes by TBK1-mediated phosphorylation.
The simultaneous inhibition of HDACs and BET proteins has shown promising anti-proliferative effects against different cancer types, including the difficult to treat pancreatic cancer. In this work, the strategy of concurrently targeting HDACs and BET proteins was pursued by developing different types of dual inhibitors.
By developing a novel scaffold that selectively inhibits HDAC1/2 together with BET proteins in cells, an effective tool for the investigation of pancreatic cancer, and other diseases which are sensitive to epigenetic processes, was created. The compound’s small size further gives the opportunity to further develop the inhibitor towards optimized pharmacokinetic properties, potentially resulting in a drug for cancer treatment.
A second novel approach that was pursued, was the development of a small-molecule degrader, targeting HDACs and BET proteins. Through synthesizing a variety of different molecules, a compound that was capable of lowering BRD4 levels and, at the same time, increasing histone acetylation was developed. While additional mechanistic investigations are needed to verify the degradation, the potent antiproliferative effects in pancreatic cancer cells encourage further studies following this alternative new strategy.
Nicotinamide adenine dinucleotide (NAD) serves as a cap-like structure on cellular RNAs (NAD-RNAs) in all domains of life including the bacterium Escherichia coli. NAD also acts as a key molecule in phage-host interactions, where bacterial immune systems deplete NAD to abort phage infection. Nevertheless, NAD-RNAs have not yet been identified during phage infections of bacteria and the mechanisms of their synthesis and degradation are unknown in this context. The T4 phage that specifically infects E. coli presents an important model to study phage infections, but a systematic analysis of the presence and dynamics of NAD-RNAs during T4 phage infection is lacking. Here, we investigate the presence of NAD-RNAs during T4 phage infection in a dual manner. By applying time-resolved NAD captureSeq, we identify NAD-capped host and phage transcripts and their dynamic regulation during phage infection. We provide evidence that NAD-RNAs are – as reported earlier – generated by the host RNA polymerase by initiating transcription with NAD at canonical transcription start sites. In addition, we characterize NudE.1 – a T4 phage-encoded Nudix hydrolase – as the first phage-encoded NAD-RNA decapping enzyme. T4 phages carrying inactive NudE.1 display a delayed lysis phenotype. This study investigates for the first time the dual epitranscriptome of a phage and its host, thereby introducing epitranscriptomics as an important field of phage research.
To better understand the role of sphingolipids in the multifactorial process of inflammatory bowel disease (IBD), we elucidated the role of CerS4 in colitis and colitis-associated cancer (CAC). For this, we utilized the azoxymethane/dextran sodium sulphate (AOM/DSS)-induced colitis model in global CerS4 knockout (CerS4 KO), intestinal epithelial (CerS4 Vil/Cre), or T-cell restricted knockout (CerS4 LCK/Cre) mice. CerS4 KO mice were highly sensitive to the toxic effect of AOM/DSS, leading to a high mortality rate. CerS4 Vil/Cre mice had smaller tumors than WT mice. In contrast, CerS4 LCK/Cre mice frequently suffered from pancolitis and developed more colon tumors. In vitro, CerS4-depleted CD8+ T-cells isolated from the thymi of CerS4 LCK/Cre mice showed impaired proliferation and prolonged cytokine production after stimulation in comparison with T-cells from WT mice. Depletion of CerS4 in human Jurkat T-cells led to a constitutively activated T-cell receptor and NF-κB signaling pathway. In conclusion, the deficiency of CerS4 in T-cells led to an enduring active status of these cells and prevents the resolution of inflammation, leading to a higher tumor burden in the CAC mouse model. In contrast, CerS4 deficiency in epithelial cells resulted in smaller colon tumors and seemed to be beneficial. The higher tumor incidence in CerS4 LCK/Cre mice and the toxic effect of AOM/DSS in CerS4 KO mice exhibited the importance of CerS4 in other tissues and revealed the complexity of general targeting CerS4.
Designed multitarget ligands are a popular approach to generating efficient and safe drugs, and fragment-based strategies have been postulated as a versatile avenue to discover multitarget ligand leads. To systematically probe the potential of fragment-based multiple ligand discovery, we have employed a large fragment library for comprehensive screening on five targets chosen from proteins for which multitarget ligands have been successfully developed previously (soluble epoxide hydrolase, leukotriene A4 hydrolase, 5-lipoxygenase, retinoid X receptor, farnesoid X receptor). Differential scanning fluorimetry served as primary screening method before fragments hitting at least two targets were validated in orthogonal assays. Thereby, we obtained valuable fragment leads with dual-target engagement for six out of ten target combinations. Our results demonstrate the applicability of fragment-based approaches to identify starting points for polypharmacological compound development with certain limitations.
Neurleptic drugs, e.g., aripiprazole, targeting the dopamine D2S and D3 receptors (D2SR and D3R) in the central nervous system are widely used in the treatment of several psychotic and neurodegenerative diseases. Therefore, a new series of benzothiazole-based ligands (3-20) was synthesized by applying the bioisosteric approach derived from the selective D3Rs ligand BP-897 (1) and its structurally related benz[d]imidazole derivative (2). Herein, introduction of the benzothiazole moiety was well tolerated by D2SR and D3R binding sites leading to antagonist affinities in the low nanomolar concentration range at both receptor subtypes. However, all novel compounds showed lower antagonist affinity to D3R when compared to that of 1. Further exploration of different substitution patterns at the benzothiazole heterocycle and the basic 4-phenylpiperazine resulted in the discovery of high dually acting D2SR and D3R ligands. Moreover, the methoxy substitution at 2-position of 4-phenylpiperazine resulted in significantly (22-fold) increased D2SR binding affinity as compared to the parent ligand 1, and improved physicochemical and drug-likeness properties of ligands 3-11. However, the latter structural modifications failed to improve the drug-able properties in ligands having un-substituted 4-phenylpiperazine analogs (12-20). Accordingly, compound 9 showed in addition to high dual affinity at the D2SR and D3R [Ki (hD2SR) = 2.8 ± 0.8 nM; Ki (hD3R) = 3.0 ± 1.6 nM], promising clogS, clogP, LE (hD2SR, hD3R), LipE (hD2SR, hD3R), and drug-likeness score values of −4.7, 4.2, (0.4, 0.4), (4.4, 4.3), and 0.7, respectively. Also, the deaminated analog 10 [Ki (hD2SR) = 3.2 ± 0.4 nM; Ki (hD3R) = 8.5 ± 2.2 nM] revealed clogS, clogP, LE (hD2SR, hD3R), LipE (hD2SR, hD3R) and drug-likeness score values of −4.7, 4.2, (0.4, 0.4), (3.9, 3.5), and 0.4, respectively. The results observed for the newly developed benzothiazole-based ligands 3-20 provide clues for the diversity in structure activity relationships (SARs) at the D2SR and D3R subtypes.
This thesis comprises the usage of two commonly known hinge-binding moieties in drug discovery. First, the quinazoline scaffold of gefitinib (5) was utilized in a macrocyclization strategy to introduce selectivity. In general, the quinazoline hinge-binding moiety is a commonly used scaffold which can be found in 14% of approved kinase inhibitors. The most familiar applications are EGFR inhibitors such as gefitinib (5), erlotinib (6), afatinib, or dacomitinib for the treatment of NSCLC. But other kinases like CDK2, CDK4, or p38 are reported targets as well.
The N-phenylquinazolin-4-amine moiety of gefitinib (5) was conserved however, the residues at the aromatic ring in the linker were modified, the residue targeting the solvent-exposed region was varied, and the linker at the C6 position of the quinazoline was adjusted to enable the macrocyclization. An overview of the structural modifications is shown in Figure 35A.
Kinome-wide screening of gefitinib (5) revealed several off-targets besides EGFR (Figure 35B), making it an excellent starting point for a macrocyclization strategy. Introducing a linker to the N phenylquinazoline-4-amine scaffold and retaining the residues on the aromatic ring as well as the methoxy group targeting the solvent-exposed region improved the selectivity profile and the efficacy towards EGFR WT and its mutants. Truncation of the linker moiety led to the mutant selective macrocycle 26f with an excellent kinome-wide selectivity profile (Figure 35B). An inhibitor that is effective on EGFR mutations while ineffective on the EGFR WT could represent an enhancement of patient treatment, as it potentially causes less side effects. Further studies could determine the effect of the most promising macrocycles in lung cancer cell lines. Additionally, the pharmacokinetic properties could be optimized, e.g. by introducing solubilizing groups, targeting the solvent-exposed region.
The second scaffold comprises the 3-aminopyrazole-based hinge-binding moiety. It is a privileged scaffold in medicinal chemistry for the development of kinase inhibitors. Previous publications report the anti-proliferative and anti-cancer potential of pyrazole-based molecules. They play a crucial role in the treatment of various diseases and cancer types like inflammation disorders, lymphoma, or breast cancer. This scaffold can be found e.g. in the aurora kinase inhibitor tozasertib or in the promiscuous kinase inhibitor 23, published by Statsuk et. al. Rescreening compound 23 in a comprehensive kinase panel against 468 human protein kinases confirmed the unselective behavior with a selectivity score of S35 = 0.56 (Figure 36B), making it a great starting point for further optimizations. The N-(1H-pyrazol-3-yl)pyrimidin-4-amine scaffold was conserved however, the residues targeting the solvent-exposed region were varied and different linkers were attached.
The introduction of different residues at the pyrazole dramatically influenced the selectivity profile of the desired kinases. Ester moieties caused to a favorable combination of selectivity and potency towards the kinase of interest CDK16. The removal of additional residues at the pyrimidine, targeting the solvent-exposed region, increased the efficiency towards CDK16. Further optimization led to the highly potent and selective CDK16 inhibitor 98d (IC50 = 33 nM). NanoBRETTM screening against the complete CDK family revealed a preferred inhibition of the PCTAIRE and PFTAIRE subfamily with cellular IC50 values of 20 nM – 120 nM and 50 nM – 180 nM, respectively. A FUCCI cell cycle assay and viability assessment of 98d confirmed previously published results, reporting a G2/M cell cycle arrest followed by apoptosis and accumulation of p27 through knockout of CDK16 in SCC cells. Consequently, further studies could evaluate the anti-tumor activity of 98d in SCC and NSCLC or elucidate the effect of 98d in AMPK-related macroautophagy. 98d represents a novel tool compound to investigate the understudied kinases of the PCTAIRE family and enable to enlighten the biological role of those kinases.
Macrocyclization of the N-(1H-pyrazol-3-yl)pyrimidin-4-amine core resulted in the selective BMPR2 inhibitor 110a. It showed a good binding affinity towards BMPR2 with a KD value of 205 nM as well as a good potency with an IC50 value of 506 nM. A comprehensive selectivity screen against 468 kinases revealed an excellent selectivity profile with S35 = 0.01. As no BMPR2 inhibitors have been published so far, 110a represents a novel compound that may provide further insights into the canonical BMP pathway, noncanonical signaling, or its impact on BMPR2-associated diseases like PAH.
The introduction of additional residues targeting the solvent-exposed region shifted the selectivity towards the MST kinases. The exchange from the pyrimidine to a quinazoline moiety resulted in the highly potent and selective macrocyclic MST3 inhibitor 113c. NanoBRETTM measurements demonstrated the preferred inhibition of MST3 with IC50 values of 210 nM and 30 nM for intact and lysed cells, respectively. A weaker activity could be seen for MST4 with 1.8 µM and 510 nM, while MST1 and MST2 were not affected. To date, no selective MST3 inhibitors have been published, making 113c a valuable tool compound for further functional studies. As MST3 is influencing the cell cycle progression, 113c could be tested in a further cell cycle assay to elucidate the inhibitory effect of 113c on MST3 and consequently on the cell cycle. Furthermore, the anti-tumor activity of 113c in breast cancer could be determined, as Madsen et. al. reported a high MST3 and MST4 activity triggered by FAM40B mutations.
The p38α mitogen-activated protein kinase (MAPK) is activated through stress stimuli such as heat shock or hypoxia. In the nucleus, p38α modulates the activity of other kinases and transcription factors, a process that regulates the expression of specific target genes, most importantly pro-inflammatory cytokines. Dysregulation of p38α therefore plays a major role in the development of inflammatory diseases such as rheumatoid arthritis. Despite many years of intensive research, no p38 small-molecule inhibitors have been approved yet. Several inhibitor design strategies have been reported, leading to >100-fold selective compounds for α/β over the γ and δ isoforms. Achieving such a selectivity among the two structurally most related α and β isoforms, however, remains a challenging task. Targeting an inactive DFG-out conformation offers another strategy for the development of potent kinase inhibitors (type-II), exemplified by the BCR/ABL-inhibitor Imatinib. Achieving selectivity with type-II binders is challenging, because many kinases can adopt an inactive DFG-out conformation. This is exemplified by the p38 type-II inhibitor BIRB-796, which exhibits picomolar on-target affinity but only a poor kinome-wide selectivity. A potent and selective type-II chemical probe for p38α/β was still lacking at the start of this thesis.
The promising hit VPC-00628, was chosen for a combinatorial synthetic approach to develop a type-II chemical probe. The studies covered the optimization of the hinge-binding head group, the hydrophobic region I and the DFG-out deep pocket of the lead compound VPC-00628. Selectivity for the p38α and p38β isoforms was monitored during the optimization process, which identified several inhibitors with favorable isoform selectivity, providing valuable insights into the potential of isoform-selective inhibitor design for p38. A potent and highly selective p38 MAPK probe (SR-318) was discovered, which showed IC50 values in the low nanomolar range in HEK293T cells. An unusual P-loop conformation induced upon binding of SR-318 to p38α contributed most likely to the impressive selectivity profile within the kinome that surpassed both the parent compound and BIRB-796. A negative control compound, SR-321, was developed, to distinguish between on-target effects and non-specific effects due to cross-reactivity with other cellular proteins. Studies of the metabolic stability in human liver microsomes revealed a high stability of the compounds, with only a small amount of metabolites formed over several hours. Compound SR-318 also exhibited a good in vitro efficacy, quantitatively reducing the LPS-stimulated TNF-α release in whole blood. Taken together, SR-318 is a highly potent and selective type-II p38α/β chemical probe, which will help to gain a better understanding of the catalytic and non-catalytic functions of these key signaling kinases in physiology and pathology.
The next studies focused on the exploration of the highly dynamic allosteric back pocket of p38 MAPK, and allosteric BIRB-796 derived compounds for targeting the αC- and DFG-out pockets were synthesized. Kinase activities of allosteric pyrazole-urea fragments were analyzed against a comprehensive set of 47 diverse kinases by differential scanning fluorimetry (DSF), revealing that BIRB-796 off-targets remain a problem when targeting this back-pocket binding motif. Revisiting the recently published compound MCP-081, which combines the allosteric part of BIRB-796 with the active-site directed part of VPC-00628, showed that it displays a clean selectivity profile in our kinase panel. Because the potency of MCP-081 was slightly reduced compared with VPC-00628 and the allosteric tert-butyl pyrazole moiety seemed suboptimal, a set of VPC-00628 derivatives for targeting the αC-out pocket region was synthesized. Through structure-guided extension of the terminal amide of VPC-00628 toward this allosteric site, the potent and selective compound SR-43 was developed, which showed excellent cellular activity on p38 MAPK in NanoBRETTM assays (IC50 [p38α/β] = 14.0 ± 0.1/ 16.8 ± 0.1 nM). SR-43 showed a dose-dependent inhibition of activating phosphorylation of p38 in HCT-15 cells as well as inhibition of phosphorylation of p38 downstream substrates MK2 and Hsp27. In addition, SR-43 induced an anti-inflammatory response by blocking TNF-α release in whole blood and displayed a high metabolic stability. Selectivity profiling of SR-43 revealed a narrow selectivity for additional targets such as the discoidin domain receptor kinases (DDR1/2). DDR kinases play a central role in fibrotic disorders, such as renal and pulmonale fibrosis, atherosclerosis and different forms of cancer. Since selective and potent inhibitors for these important therapeutic targets are largely lacking and the existing inhibitors are of low scaffold diversity, the next study focused on the optimization of SR-43 toward DDR1/2 kinase inhibition. The synthetic work covered the optimization of the hinge-binding head group and the allosteric part of SR-43 toward DDR1/2 kinase inhibition. These studies provided novel insights into the P-loop folding process of p38 MAPK and how targeting of non-conserved amino acids affects inhibitor selectivity. Importantly, they led to the development of a selective dual DDR/p38 inhibitor probe, SR-302, with picomolar affinity for DDR2. SR-302 was efficient in vitro and showed a destabilizing effect on the surface adhesion protein E-cadherin in epithelial cells. In summary, SR-302 and its negative control SR-301 provide a valuable tool set for studying the phenotypic effects of DDR1/2 signaling, e.g., in cancer cell lines.
Lead-optimization strategies for compounds targeting c-Myc G-quadruplex (G4) DNA are being pursued to develop anticancer drugs. Here, we investigate the structure-activity- relationship (SAR) of a newly synthesized series of molecules based on the pyrrolidine-substituted 5-nitro indole scaffold to target G4 DNA. Our synthesized series allows modulation of flexible elements with a structurally preserved scaffold. Biological and biophysical analyses illustrate that substituted 5-nitroindole scaffolds bind to the c-Myc promoter G-quadruplex. These compounds downregulate c-Myc expression and induce cell-cycle arrest in the sub-G1/G1 phase in cancer cells. They further increase the concentration of intracellular reactive oxygen species. NMR spectra show that three of the newly synthesized compounds interact with the terminal G-quartets (5′- and 3′-ends) in a 2 : 1 stoichiometry.
This work focused on the biosynthesis and characterization of esterified lipid mediators. Lipid mediators were generally thought to exert their effects as free molecules, and their esterification was regarded as a storage mechanism. However, more recent studies indicate that esterified lipid mediators are a distinct class of mediators. When this thesis started back in 2017, the idea of esterified lipids as a new class of mediators was relatively new so that respective compounds were either quite expensive or not commercially available at all. Therefore, a biosynthetic approach had to be established first to enable the study of the new lipid mediator class. Within the cell, esterified lipids are produced by activation and subsequent incorporation of polyunsaturated fatty acids. These steps are enzymatically catalyzed by members of the acyl-CoA synthetase family and the lysophosphatidylcholine acyltransferase family, respectively. Therefore, the enzymes acyl-CoA synthetase long-chain family member 4 (ACSL4) and lysophosphatidylcholine acyltransferase 2 (LPCAT2) were selected for a biosynthetic approach due to their broad substrate acceptance.
In a first attempt, recombinant protein expression in E. coli was studied. While the expression and purification of C-terminally His6x-tagged ACSL4 resulted in a pure and active protein, the expression of LPCAT2 turned out quite troublesome. Although several expression and purification parameters were varied, including purification tags, buffer compositions, and chromatography strategies, successful purification of LPCAT2 was not achieved.
Instead, a second approach was studied. This time, stably transfected cells overexpressing ACSL4 and/or LPCAT2 were generated from the human embryonal kidney (HEK) 293T cell line. Stably transfected cell lines were characterized on protein level and regarding their oxylipin profile. After confirming the overexpression and functionality of the enzymes, lipoxygenases (LOs) were co-expressed in a doxycycline-inducible manner to prevent premature cell death due to increased oxidative stress. As a result, LO product formation was enhanced and enabled the investigation of specific oxylipins. Since increased lipid peroxidation is also a key component of the ferroptosis cell death mechanisms, cell lines were investigated towards their cell viability. Indeed, expression of ACSL4 and/or LPCAT2 promoted cell death when treated with the ferroptosis inducers erastin or RSL3, even in the absence of LO expression. Furthermore, analysis by laser scanning confocal microscopy revealed that the localization of 15-LO1 was altered in the presence of LPCAT2, similar to treatment with RSL3 in vector control cells.
In conclusion, a stable overexpression system of ACSL4 and/or LPCAT2 was successfully established in HEK293T cells, which enabled the synthesis and characterization of esterified oxylipins. Interestingly, characterization of the cell lines revealed a correlation with the cell death mechanism ferroptosis. Although the expression of ACSL4 has already been reported as a biomarker for ferroptosis, this is the first time that a potential connection of LPCAT2 with ferroptosis was demonstrated. As a result, this may provide new therapeutic options for ferroptosis-related pathologies such as neurodegeneration, autoimmune diseases, or tumorigenesis.
Die vorliegende Arbeit beschreibt die Herstellung von codierten Peptidbibliotheken durch kombinatorische Synthese, sowie deren Selektion auf Wechselwirkung mit einer verkürzten Sequenz der TAR-RNA des HI-Viruses.
Die zur Selektion benötigte RNA wurde dazu auf chemischem Wege hergestellt und mit einem Fluoreszensfarbstoff für eine optische Selektion markiert. Ausgehend von dieser RNA wurde ein Anfärbeassay entwickelt. Bei der Anwendung des Assays auf Tri- und Pentapeptide, die auf einem Polymerträger immobilisiert waren, zeigten sich einige intensiv leuchtende Polymerkügelchen. Die hellsten unter ihnen wurden selektiert. Die Synthese der Trimeren und Pentamerenbibliothek erfolgte zuvor an wasserquellbarem, polymerem Trägermaterial. Die Identifizierung der polymergebundenen Verbindungen erfolgte über die Codierung nach W.C. Still, welche im Rahmen dieser Dissertation in der Arbeitsgruppe von Hr. Prof. Göbel erfolgreich etabliert wurde und die einfache Unterscheidung zwischen Enantiomeren ermöglicht. Drei der am häufigsten auftretenden Trimerensequenzen wurden im Nachhinein erneut synthetisiert und Experimenten an Zellen zugeführt. Unabhängig davon, wurde ihre Wechselwirkung mit RNA als auch mit RNA-Peptid Komplexen direkt getestet.
Weiterhin wurde exemplarisch anhand von Aminopyridinen die Möglichkeit getestet, neuartige Synthesemonomere für die automatische Synthese polymergebundener Verbindungen darzustellen.
Die vorliegende Arbeit macht deutlich, dass man durch kombinatorische Synthese im Verbund mit gerichteter Selektion, die Entwicklung von in vitro RNA-Liganden für RNA mit bekannter Struktur vorantreiben kann. Umgekehrt müsste dies auch bald die Selektion von Liganden für strukturell nicht charakterisierte RNA ermöglichen.
Das nächste Ziel sollte, die Entwicklung weiterer Selektionstests sein und die Etablierung von NMR-Methoden, welche die genauen Bindungsmodi der selektierten Verbindungen an RNA aufklären, um somit die gezielte Synthese neuartiger Liganden vorantreiben zu können, da letztendlich das "Wie", für die Weiterentwicklung einer Leitstruktur ausschlaggebend ist.
Weiterhin sollten die Transportmechanismen von körperfremden Substanzen zu dem gewünschten Wirkort studiert werden, damit die vorab in vitro getestete Substanz auch im späteren Entwicklungsstadium in vivo die gewünschten Eigenschaften zeigen kann.
Photolabile Schutzgruppen haben sich im Laufe der letzten Jahre als wertvolle Werkzeuge für die Untersuchung und Regulation biologischer Prozesse etabliert. Dabei wird die photolabile Schutzgruppe auf geeignete Weise mit Biomolekülen verknüpft, sodass deren Funktion temporär deaktiviert wird. Durch Bestrahlen mit Licht geeigneter Wellenlängen wird die photolabile Schutzgruppe entfernt und die Aktivität des Biomoleküls bzw. des zu beobachtenden Prozesses wiederhergestellt. Die Grundlagen der Verwendung photolabiler Schutzgruppen im biologischen Kontext wurden in zwei Pionierarbeiten 1977 von J.W. ENGELS und 1978 von J.F. HOFFMAN gelegt. Davon ausgehend haben sich zahlreiche Anwendungen photolabiler Schutzgruppen für biologisch interessante Molekülklassen entwickelt. Auf dem speziellen Gebiet der Nukleinsäuren wurden in den letzten Jahren einige fundamentale Mechanismen entdeckt und aufgeklärt, die nicht zuletzt auch therapeutisch interessante Anwendungsmöglichkeiten für photolabile Schutzgruppen bieten. Hierbei stellt das An-/Aus-Schaltverhalten von Nukleinsäuren jedoch ein nicht-triviales Problem dar. Selbst der gezielte Einbau einer einzelnen photolabilen Schutzgruppe in ein multifunktionales Oligonukleotid führt in der Regel nämlich nicht zu einer vollständigen Deaktivierung dessen. Ein multipler Einbau photolabiler Schutzgruppen entlang der Sequenz eines funktionellen Oligonukleotids schaltet die Hintergrundaktivität im deaktivierten Zustand zwar vollständig aus, allerdings müssen in diesem Fall hohe Bestrahlungsintensitäten bzw. –dauern für das Entfernen aller photolabilen Modifikationen angewendet werden. Dadurch geht zum einen die Zeitauflösung der lichtgeschalteten Prozesse verloren, nicht zuletzt erhöht sich dabei aber auch das Risiko von lichtinduzierten Schäden am biologischen System. Das Kernthema der vorliegenden Dissertation war es daher, neue Architekturen für den Aufbau photoaktivierbarer Oligonukleotide zu entwickeln.
Das erste große Projekt basierte auf der Annahme, dass sich Duplexstrukturen, die für die Funktion vieler Nukleinsäuremechanismen fundamental sind, durch Zyklisierung von Oligonukleotiden global destabilisieren und damit effizienter photoaktivieren lassen, als durch lokalen Einbau einzelner photolabiler Schutzgruppen in Oligonukleotide. Hierzu wurden geeignete Alkin-Modifikationen an photolabile Nitrobenzyl- und Cumarin-Schutzgruppen angebracht und diese an die Nukleobasen verschiedener DNA-Bausteine geknüpft. Es ist daraufhin gelungen, Oligonukleotide mit je zwei photolabilen Alkin-Modifikationen herzustellen und diese intrasequentiell über eine Cu(I)-katalysierte Click-Reaktion mit einem Bisazid-Linker zu zyklisieren. Die so erhaltenen Oligonukleotide wiesen dramatisch erniedrigte Schmelzpunkte gegenüber den nativen Duplexen, sowie gegenüber den zweifach photolabil geschützten Oligonukleotiden auf. Dabei wurde außerdem festgestellt, dass Zyklisierungsparameter wie die Linkerlänge, -polarität und –flexibilität und die Wahl der photolabilen Schutzgruppe keinen signifikanten Einfluss auf die Duplexstabilität hat. Über einen Bereich von Ringgrößen zwischen ca. 11-21 Nukleotiden wurden die niedrigsten Duplexstabilitäten beobachtet. Sehr kleine, sowie große Ringe ab 30 Nukleotiden wiesen dagegen höhere Stabilität auf.
Da mit dem entwickelten Zyklisierungskonzept auch mehrere Ringstrukturen innerhalb einer Oligonukleotidsequenz aufgebaut werden können, wurde im nächsten Schritt eine photoaktivierbare Variante des C10-Aptamers hergestellt, welches selektiv gegen Burkitt’s Lymphomzellen bindet. Dieses 90-mer DNA-Oligonukleotid wurde an drei Stellen photolabil Alkin-modifiziert und infolge mit einem Trisazid-Linker zu einer bizyklisierten Struktur verknotet. Mit Hilfe von Fluoreszenzmikroskopie-Experimenten konnte demonstriert werden, dass das durch eine solche „Photo-Klammer“ deaktivierte C10-Aptamer keine Bindungsaffinität gegenüber Burkitt’s Lymphomzellen aufweist, die Bindungsaktivität jedoch nach Belichten wiederhergestellt werden kann. Mit Atomkraftmikroskopie-Experimenten ist es darüber hinaus gelungen, die Photoaktivierung des verknäuelten C10-Aptamers mit molekularer Auflösung abzubilden. Mit diesem Ergebnis können nun lange funktionelle Oligonukleotide auf definierte Weise photoaktivierbar gestaltet werden, insbesondere auch dann, wenn keine (Informationen über) funktionelle Sekundärstrukturen existieren.
...
Synthese und Struktur-Wirkungsbeziehungen neuer rezeptorselektiver Dopamin-D 2- und -D 3-Liganden
(2003)
Dopaminrezeptoren gehören zur Familie der G-Protein-gekoppelten Rezeptoren, der bisher größten Rezeptorklasse. Seit der Identifizierung der zuvor unbekannten Rezeptorsubtypen D3-D5 in den Jahren 1990 und 1991 hat die Erforschung des dopaminergen Systems neuen Anschub erhalten, der maßgeblich auf das spezifische Vorkommen jeweiliger Subrezeptoren in diskreten Hirnarealen zurückzuführen ist. Während dopaminerge Neuronen an neurologischen und psychiatrischen Störungen wie Morbus Parkinson, Schizophrenie und Drogenmißbrauch bzw. -abhängigkeit seit geraumer Zeit in einen ursächlichen Zusammenhang gebracht werden, begründen die unterschiedlichen Charakteristika der Rezeptorsubtypen hinsichtlich Lokalisation, Aminosäuresequenz und pharmakologischem Verhalten die Hoffnung, mit subrezeptorselektiven Wirkstoffen neue therapeutische Ansätze verwirklichen zu können, die eine Reduktion der gravierenden, mit bisherigen Therapiekonzepten korrelierten Nebenwirkungen erlauben. In der vorliegenden Arbeit wurden, ausgehend von den D2- und D3-rezeptorbevorzugenden Wirkstoffen ST 177, L-741,626, ST 314, NAN190, ST 198 und BP 897, gezielte Modifikationen an unterschiedlichen Molekülteilen unternommen, um ihre jeweils charakteristischen pharmakologischen Eigenschaften stärker zu profilieren.
Zur Behandlung von chronisch entzündlichen Erkrankungen besteht nach wie vor ein dringendes medizinisches Bedürfnis, da die bisher eingesetzten Medikamente gerade in der Langzeittherapie zu schwerwiegenden Nebenwirkungen führen können. Um chronisch entzündliche Erkrankungen in Zukunft adäquat therapieren zu können, sind bereits verschiedene neuartige Ansätze in klinischer bzw. präklinischer Entwicklung. Ein möglicher Ansatz besteht in einer dualen Hemmung der mikrosomalen Prostaglandin E2 Synthase-1 (mPGES-1) und der 5-Lipoxygenase (5-LO). Im Rahmen dieser Arbeit wurden die Struktur-Wirkungs-Beziehungen (SAR) von zwei verschiedenen Leitstrukturen an der 5 LO und der mPGES 1 untersucht. Die erste Leitstruktur entstammt aus den Arbeiten von Waltenberger et al. und besitzt im Grundgerüst eine Sulfonamidstruktur. In dieser Arbeit ist es gelungen, durch eine gezielte Untersuchung der Struktur-Wirkungsbeziehungen, die Leitstruktur I an der 5 LO und der mPGES-1 in ihrer Potenz zu optimieren. Die Leitstruktur (IC50: 5-LO (zellfrei) = 5.7 µM, IC50: 5 LO (PMNL) = 3.7 µM, IC50: mPGES-1 = 4.5 µM) konnte durch Variation in allen drei Positionen modifiziert werden, so dass die optimierte Struktur 170 (IC50: 5-LO (zellfrei) = 2.3 µM, IC50: 5-LO (PMNL) = 0.4 µM, IC50: mPGES-1 = 0.7 µM) entstanden ist. Für die Verbindung 170 wurden die pharmakokinetischen Eigenschaften, wie Löslichkeit und metabolische Stabilität, sowie der Wirkmechanismus auf molekularer Ebene bestimmt. Ebenso konnte für Verbindung 170 auch in vivo anti-entzündliche Eigenschaften festgestellt werden.
Die zweite Leitstruktur stammt ebenfalls aus den Arbeiten von Waltenberger et al. und besitzt im Grundgerüst eine Mercaptobenzothiazol-Grundstruktur. Aufgrund der Ähnlichkeit zu den bekannten Pirinixinsäurederivaten wurde auch hier für die Untersuchung der Struktur-Wirkungs-Beziehungen zunächst eine Kettenverlängerung an der Alkylkette vorgenommen. Es ließ sich auch hier durch eine gezielte SAR, die Leitstruktur bis hin zum submikromolaren Bereich in Verbindung 219 optimieren. Gleichzeitig ist es gelungen in Verbindung 219 einer der am potentesten dual ausgeglichensten dualen 5 LO/mPGES-1 Inhibitoren zu identifizieren.
Zusammenfassend lässt sich sagen, dass in dieser Arbeit es gelungen ist durch gezielte Untersuchungen der Struktur-Wirkungs-Beziehungen zwei verschiedene Substanzklassen zu dualen 5-LO/mPGES-1 Inhibitoren zu optimieren. Ebenso konnte für Substanz 170 auch in vivo anti-entzündliche Eigenschaften festgestellt werden. Diese Arbeit soll dazu beitragen, das therapeutische Potential von dualen 5-LO/mPGES-1 Inhibitoren als anti-entzündliche Wirkstoffe in Zukunft besser einschätzen zu können.
Im Rahmen der vorliegenden Arbeit wurden Inhibitoren der bakteriellen Resistenzproteine New Delhi Metallo-β-Lactamase 1 (NDM-1), die beiden Mutanten der Verona-Integron Encoded Metallo-β-Lactamase 1 und 2 (VIM-1, bzw. -2), sowie die Imipenemase 7 (IMP-7) entwickelt.
Auf Grund natürlicher Selektion, aber vor allem auch bedingt durch den unüberlegten und verschwenderischen Einsatz von β-Lactam-Antibiotika, ist eine weltweite Zunahme an multiresistenten Erregern zu beobachten. Einer der Hauptgründe dieser Resistenzen sind die Metallo- β-Lactamsen (MBL), welche vor allem in Gramnegativen Bakterien vertreten sind und für die Hydrolyse und damit der Desaktivierung der β-Lactam-Wirkstoffe verantwortlich sind. Neben der Suche nach anderweitig wirkenden Antibiotika, ist die Entwicklung von Inhibitoren der MBLs von vordringlicher Bedeutung.
Basierend auf der Grundstruktur des ACE-Hemmers Captopril, wurden trotz synthetischer Herausforderungen erfolgreich mehrere Strukturen mit inhibitorischer Aktivität gegenüber den MBLs synthetisiert. Der Prolinring von Captopril wurde in einer neuen Variante der Captopril-Synthese durch verschiedene Ring- und nicht cyclische Teilstrukturen ersetzt. Durch die Entwicklung einer Schutzgruppenstrategie, konnte die Ringstruktur durch einen Piperazin-Rest ersetzt werden. Dies erlaubt es, die Molekülstruktur auf dieser Seite zu erweitern. Des Weiteren wurde eine neue Syntheseroute etabliert, welche es auf elegante Weise ermöglicht, weitere Derivatisierungen an der Methylgruppe des Captoprils durchzuführen.
In einem proteinbasierten Testsystem wurden die synthetisierten Substanzen auf ihr inhibitorisches Potential hin untersucht. Dabei wurden IC50-Werte im niedrig einstelligen mikromolaren, für drei Verbindungen sogar im sub-mikromolaren Bereich ermittelt. Die erhaltenen Ergebnisse wurden für die drei aktivsten Inhibitoren durch eine Erhöhung des Schmelzpunktes in einem TSA-Testsystem erfolgreich verifiziert. Mittels ITC-Untersuchungen konnte die unterschiedlichen Gewichtungen der entropischen und enthalpischen Beiträge zur Bindung der Inhibitoren an die untersuchten MBLs aufgezeigt werden. Hierdurch konnten die scheinbar widersprüchlichen Ergebnisse der ermittelten IC50-Werte und Schmelzpunktverschiebungen für die Verbindung DBDK48 bezüglich der NDM-1 aufgeklärt werden.
Die Strukturen DB320 konnte erfolgreich mit VIM-2 co-kristallisiert werden. Dies ermöglicht eine genauere Untersuchung und qualifizierte Aussagen über die Bindungsverhältnisse zwischen Protein und Ligand.
Für zwei der synthetisierten Inhibitoren sollte untersucht werden, ob deren Aktivität in vitro auch in Bakterien erhalten bleibt. Dazu wurden pathogene klinische Isolate und Laborstämme, welche mit dem Resistenzplasmid transfiziert wurden, und gegen Imipenem resistent sind, herangezogen. Durch die Zugabe der Inhibitoren konnte die Wirksamkeit von Imipenem wiederhergestellt werden.
Es konnte eine HPLC-Methode etabliert werden, welche eine Abschätzung der Polaritäten in Abhängigkeit der Retentionszeiten erlaubt. Dadurch konnte ein direkter Zusammenhang zwischen der Polarität der Verbindungen und dem Grad der Wirksamkeit im MIC-Testsystem aufgezeigt werden.
Durch die Untersuchung der Inhibitoren auf die Proteine ACE und LTA4H, konnten zwei Ziel-Proteine der Captopril-Grundstruktur als unerwünschte Nebenziele ausgeschlossen werden. Des Weiteren führte die Behandlung von U937-Zellen, selbst bei einer hohen Konzentration von 100 µM, weder zu Auffälligkeiten in einem WST-1 Assay, noch zu einer erhöhten Freisetzung von LDH. Daher kann davon ausgegangen werden, dass die Verbindungen über keine zytotoxischen Eigenschaften verfügen.
Die Autophagie ist ein in Eukaryonten evolutionär konservierter Prozess, bei dem es zu einem lysosomalen Abbau von cytosolischen Bestandteilen kommt. Die dabei entstehenden biochemischen Bausteine stehen anschließend erneut zum Aufbau benötigter Strukturen zur Verfügung. Verschiedene Stimuli, wie beispielsweise Nährstoffmangel, können die Aktivität der Autophagie erhöhen und ermöglicht Zellen dadurch die Aufrechterhaltung der Zellhomöostase, selbst unter Stressbedingungen. Im Verlauf der Autophagie bildet sich eine tassenförmige Doppelmembran-Struktur, das sogenannte Phagophor. Dieses wächst, um das abzubauende Material zu umschließen und wird dabei von sogenannten Atg-Proteinen (autophagy-related genes) prozessiert. Nach der Schließung spricht man vom Autophagosom, welches letztlich mit einem Lysosom verschmilzt und das Autophagolysosom bildet, welches wiederum die eingeschlossenen Bestandteile zerlegt und die recycelten Bausteine freigibt. Die einzelnen Schritte während der Autophagie sind hochgradig durch die Atg-Proteine reguliert. Eines dieser Atg-Proteine, das Atg8, ist an einigen entscheidenden Schritten wie dem Phagophor-Wachstum, der Autophagosom-Reifung sowie der Schließung beteiligt. Während es in Hefen nur ein einziges Atg8-Protein gibt, so zeigt sich in höheren Eukaryonten meist eine gewisse Diversität. So codiert beispielsweise das humane Genom mindestens sechs Atg8-Homologe. Neben den drei Proteinen der LC3-Familie (A, B, C) zählen auch GABARAP, GABARAPL1 und GABARAPL2 dazu. Die Gründe für diese Diversität sind noch nicht vollständig aufgeklärt, weshalb es wichtig ist, möglichst selektive Modulatoren zu entwickeln, um so die Aufgaben der einzelnen Homologen entschlüsseln zu können. Eine weitere wichtige Aufgabe übernimmt Atg8 beim Binden des abzubauenden Materials über sogenannte Autophagie-Rezeptoren, wie beispielsweise p62. Der Bindevorgang beruht dabei auf der Interaktion von p62 mit ubiquitinierten Zellbestandteilen auf der einen Seite und der Interaktion zwischen p62 und LC3 auf der anderen Seite. Letztgenannte beruht auf dem Binden des LIR-Motivs (LC3-interagierende Region) von p62 an die LDS (LIR-docking site) des LC3-Proteins. Das LIR-Motiv zeichnet sich durch Aminosäure-Sequenz D-D-D-W/F/Y-X1-X2-L/I/V aus. Währende die aromatische Seitenkette (W/F/Y) die hydrophobe Tasche 1 (HP1) der LDS besetzt, ragt die aliphatische Seitenkette (L/I/V) in die HP2 hinein. Damit sollte es möglich sein, die LIR-LC3-Interaktion, durch das Besetzen der LDS zu stören bzw. zu inhibieren. Solche Inhibitoren könnten zum einen der weiteren Aufklärung der Prozesse, an denen die Autophagie beteiligt ist, dienen, zum anderen jedoch auch die Untersuchung fehlerhafter Autophagie ermöglichen. Ausgangspunkt für diese Arbeit stellt die Verbindung Novobiocin dar, die im Rahmen eines Mitteldurchsatz-Screenings als potenzieller Inhibitor der LIR-LC3-Interaktion identifiziert und mittels ITC, TSA und 1H-15N-HSQC verifiziert werden konnte. Die Struktur des Novobiocins setzt sich aus dem 3-Amino-4-hydroxy-8-methylcoumarin-Kern, der über eine Amidbindung an 3-iso-Prenyl-4-Hydroxybenzoesäure gebunden ist, sowie einer O-glykosidischen Bindung in Position C7 des Coumarins mit L-Noviose zusammen. Da es sich bei Novobiocin (XL6) um ein verhältnismäßig komplexes Molekül handelt, wurde der Einfluss einzelner funktionellen Gruppen des Moleküls auf die Bindungsaffinität hin untersucht. Hierfür wurden Synthesestrategien sowohl für die Coumarin-Gerüste als auch verschiedene Benzoesäuren entwickelt. Die erhaltenen Verbindungen wurden mittels ITC und TSA untersucht. Dabei wurde die Verbindung MH507 als geeigneter Ausgangspunkt für die Untersuchung der Struktur-Aktivitätsbeziehungen (SAR) bezüglich der Benzamid-Seite identifiziert. Im Rahmen einer ersten SAR-Untersuchung wurden neben verschiedenen 3-Alkyl-benzoesäuren, auch verschiedene divalente Isostere (-O-, -S-, -NHSO2-) der benzylischen Methylengruppe synthetisiert. Diese, sowie kommerzielle Aminosäuren, wurden mit 3-Amino-4,7-dihydroxycoumarin zu den entsprechenden Endverbindungen gekuppelt. Ergänzend dazu wurden auch eine Verbindung mit umgekehrter Konstitution der Amidbindung dargestellt, um den Einfluss der Reihenfolge zu verifizieren. In einer weiteren SAR-Studie wurden Derivate synthetisiert, die zusätzlich eine Funktionalisierung am C7 des Coumarin-Gerüstes über Amidkupplung, Sulfonamid-Bildung bzw. Suzuki-Reaktion erlauben und somit eine Interaktion mit der HP1 ermöglichen könnten. Dafür wurde eine weitere Synthesestrategie zur Darstellung von 7-Nitro- bzw. 7-Brom-3-amino-4-hydroxycoumarinen ausgearbeitet und eine Reihe von Endverbindungen dargestellt. Neben den Coumarin-Derivaten wurden auch vier Peptidomimetika synthetisierten. Hierfür wurde, basierend auf den Interaktionen zwischen dem LIR-Motiv und der LC3 Proteinoberfläche, ein Pharmakophor-Modell erstellt. Neben einem Pentapeptid wurden auch drei Verbindungen dargestellt, die ein 5-Amino 2-methoxybenzohydrazid-Gerüst besitzen. Um die synthetisierten Verbindungen auf ihre inhibitorische Aktivität auf LC3A bzw. LC3B gegenüber dem LIR-Motiv von p62 hin untersuchen zu können, wurde ein HTRF-basierter Verdrängungsassay entwickelt. Dabei diente ein mit dem LIR-Motiv modifiziertes sGFP als FRET-Akzeptor, während das jeweilige Terbium-Kryptat-gelabelte SNAP-LC3-Fusionsprotein als FRET-Donor fungierte. Neben den Titrationsexperimenten zur Bestimmung der IC50-Werte wurden auch die jeweiligen Dissoziationskonstanten (Kd) von LC3A und LC3B gegenüber dem LIR-sGFP-Fusionsprotein bestimmt, um die IC50-Werte in inhibitorische Konstanten (Ki) zu überführen, da diese untereinander besser vergleichbar sind.
Die Verbindung MH209 zeigte die höchste Aktivität auf LC3A bzw. LC3B und besitzt aufgrund der Noviose-Einheit eine gute Wasserlöslichkeit, weshalb sie für die weiteren Untersuchungen ausgewählt wurde. Im Zuge von Kristallisationsexperimenten gelang die Isolierung und Vermessung eines Co-Kristalls von LC3A mit Verbindung MH209. Durch die Kristallstruktur wurden wichtige Einblicke in die intermolekularen Wechselwirkungen der 4-Hydroxycoumarine mit der LC3A- bzw. LC3B-Proteinoberfläche gewonnen und die Bindungsmode aufgeklärt. Diese Erkenntnisse passen gut zu den Ergebnissen aus den durchgeführten TSA-, ITC- und HTRF-Assays, wie beispielsweise der korrekten Konstitution der Amidbindung am C3 des Coumarin-Gerüstes. Mittels ITC wurde die Verbindung MH209 auf ihre Bindungsaffinität gegenüber den anderen humanen Homologen der Atg8-Proteinfamilie hin untersucht. Dabei zeigte sich, dass MH209 abgesehen von LC3A und LC3B keinerlei Aktivität auf den humanen Atg8-Homologen besitzt. Diese Selektivität ist nützlich, um die biologische Bedeutung der Diversität von Atg8-Homologen in höheren Eukaryonten zu untersuchen und Prozesse, in die diese involviert sind, aufzuklären.
In dieser Arbeit konnte 1,8-Diborylnaphthalin (11) präparativ in einer Stufe und 65% Ausbeute aus dem literaturbekannten Boronsäureanhydrid 9 dargestellt werden. 11 ist das zweite bekannte, aromatisch verbrückte Derivat des Diborans B2H6. 11 kann als Startverbindung für eine Reihe strukturverwandter BNB-dotierter Phenalenderivate verwendet werden. Dazu werden zwei der vier Bor-gebundenen Protonen durch die Umsetzung mit einem Mesitylgrignard und Trimethylsilylchlorid substituiert. Die Umsetzung mit Wasser bzw. Aminen liefert BOB- bzw. BNB-Phenalene unter Freisetzung von elementarem Wasserstoff. Alle, auf diese Weise dargestellten Verbindungen, zeigen reversible Redoxeigenschaften und Photolumineszenz mit zum Teil besonders scharfen Emissionssignalen mit Halbhöhenbreiten von bis zu 31 nm. Zusätzlich wurden drei analoge Vertreter einer NBN-Phenalen Spezies dargestellt und charakterisiert. Die entgegengesetzte Dotierung äußert sich in einem grundlegend verschiedenem Redoxverhalten. Abschließend wurde die Reduktion des BNB-Phenalens 22 untersucht. Dabei gelang es das Radikal K[32] zu charakterisieren und seine Abbaureaktion in THF aufzuklären.
Nukleinsäuren und Proteine bilden zusammen mit den Kohlenhydraten und Lipiden die vier großen Gruppen der Biomoleküle. Dabei setzen sich Nukleinsäuren aus einer variierenden Abfolge von Nukleotiden zusammen. Gleiches trifft auf die Proteine zu, wobei deren Bausteine als Aminosäuren bezeichnet werden. Die Reihenfolge der Bausteine bestimmt zusammen mit der Interaktion, die die einzelnen Bestandteile untereinander eingehen, deren Funktion. Um deren Wirkungsweise verstehen und nachverfolgen zu können, wurden unterschiedliche Methoden entwickelt, zu welchen auch die EPR-Spektroskopie gehört.
Durch den Einbau modifizierter Nukleotide oder Aminosäuren lassen sich Spinlabel in die sonst EPR-inaktiven Nukleinsäuren und Proteine einführen. Diese Marker lassen sich grundsätzlich in drei Klassen unterteilen (Metallionen, Nitroxidradikale und TAMs), weisen aber immer mindestens ein ungepaartes Elektronenpaar auf. Die Festphasensynthese ist eine Standardprozedur zur Herstellung von markierten Nukleinsäuren und Proteinen. Allerdings führen die Bedingungen dieser Methode zumindest teilweise zur Zersetzung der Nitroxidradikale, die dieser Arbeit zugrunde liegen, wenn sie direkt während der Synthese eingebaut werden. Der direkte Einbau ist aber in vielen Fällen essenziell, um bestimmte Eigenschaften zu erzielen.
Um den Abbau des Nitroxidradikals während der Festphasensynthese zu verhindern, kann dieses vorübergehend mit einer Schutzgruppe versehen werden, welche sich anschließend wieder abspalten lässt.
Der Schwerpunkt dieser Arbeit liegt hierbei auf der Darstellung neuer photolabil geschützter Spinlabel zur Synthese markierter Proteine und Nukleinsäuren.
Basierend auf den Nukleotiden Uridin und Cytidin konnten zwei für die RNA-Synthese vorgesehene Phosphoramidite synthetisiert werden, welche jeweils an der 5-Position des Pyrimidinrings mit einem photolabil geschützten Spinlabel auf Basis von TPA versehen waren. Durch Einbau des Uridinderivats in das Neomycin-Aptamer konnte zudem der Einfluss der Spinlabel auf die lokale Struktur mit Hilfe von in-line probing gezeigt werden.
Der gleiche TPA-Label konnte ebenfalls mit einem Lysin gekuppelt werden, welches später über ein orthogonales tRNA/Aminoacyl-tRNA Synthetase Paares in eine Polypeptid eingebaut werden sollte. In Kooperation mit dem AK Grininger ist auch ein nicht geschützter Spinlabel zur kupferfreien Markierung der Fettsäuresynthase entstanden. Abschließend war noch die Synthese eines auf Phenylalanin basierenden photolabil geschützten Spinlabel in Arbeit, welcher jedoch nicht beendet werden konnte. Dieser sollte mittels Festphasensynthese einbaubar sein, weswegen er am N-Terminus mit Fmoc geschützt ist.
Release of neuropeptides from dense core vesicles (DCVs) is essential for neuromodulation. Compared to the release of small neurotransmitters, much less is known about the mechanisms and proteins contributing to neuropeptide release. By optogenetics, behavioral analysis, electrophysiology, electron microscopy, and live imaging, we show that synapsin SNN-1 is required for cAMP-dependent neuropeptide release in Caenorhabditis elegans hermaphrodite cholinergic motor neurons. In synapsin mutants, behaviors induced by the photoactivated adenylyl cyclase bPAC, which we previously showed to depend on acetylcholine and neuropeptides (Steuer Costa et al., 2017), are altered like in animals with reduced cAMP. Synapsin mutants have slight alterations in synaptic vesicle (SV) distribution, however, a defect in SV mobilization was apparent after channelrhodopsin-based photostimulation. DCVs were largely affected in snn-1 mutants: DCVs were ∼30% reduced in synaptic terminals, and not released following bPAC stimulation. Imaging axonal DCV trafficking, also in genome-engineered mutants in the serine-9 protein kinase A phosphorylation site, showed that synapsin captures DCVs at synapses, making them available for release. SNN-1 co-localized with immobile, captured DCVs. In synapsin deletion mutants, DCVs were more mobile and less likely to be caught at release sites, and in non-phosphorylatable SNN-1B(S9A) mutants, DCVs traffic less and accumulate, likely by enhanced SNN-1 dependent tethering. Our work establishes synapsin as a key mediator of neuropeptide release.
Translational riboswitches are cis-acting RNA regulators that modulate the expression of genes during translation initiation. Their mechanism is considered as an RNA-only gene-regulatory system inducing a ligand-dependent shift of the population of functional ON- and OFF-states. The interaction of riboswitches with the translation machinery remained unexplored. For the adenine-sensing riboswitch from Vibrio vulnificus we show that ligand binding alone is not sufficient for switching to a translational ON-state but the interaction of the riboswitch with the 30S ribosome is indispensable. Only the synergy of binding of adenine and of 30S ribosome, in particular protein rS1, induces complete opening of the translation initiation region. Our investigation thus unravels the intricate dynamic network involving RNA regulator, ligand inducer and ribosome protein modulator during translation initiation.
Biogenesis of mitochondrial cytochrome c oxidase (COX) relies on a large number of assembly factors, among them the transmembrane protein Surf1. The loss of human Surf1 function is associated with Leigh syndrome, a fatal neurodegenerative disorder caused by severe COX deficiency. In the bacterium Paracoccus denitrificans, two homologous proteins, Surf1c and Surf1q, were identified, which we characterize in the present study. When coexpressed in Escherichia coli together with enzymes for heme a synthesis, the bacterial Surf1 proteins bind heme a in vivo. Using redox difference spectroscopy and isothermal titration calorimetry, the binding of the heme cofactor to purified apo-Surf1c and apo-Surf1q is quantified: Each of the Paracoccus proteins binds heme a in a 1:1 stoichiometry and with Kd values in the submicromolar range. In addition, we identify a conserved histidine as a residue crucial for heme binding. Contrary to most earlier concepts, these data support a direct role of Surf1 in heme a cofactor insertion into COX subunit I by providing a protein-bound heme a pool.
Specialized transporter proteins facilitate controlled uptake and extrusion of molecules across biological membranes that would otherwise be impermeable to them. The superfamily of solute carriers (SLC) comprises the second largest group of membrane proteins in humans, acting on a variety of small polar and non-polar molecules and ions. Because of their central role in metabolism, malfunctioning of these proteins often is pathogenic. The interest in SLC transporters as drug targets – as well as for drug delivery – has therefore increased in the past years. For many SLC subfamilies, however, structural and functional information remains scarce to date.
The here presented data provides important insights into different aspects of the transport mechanism of the SLC23 and SLC26 protein families. Importantly, we show that SLC23 nucleobase transporters, in contrast to what was been previously reported, work as uniporters rather than as proton-coupled symporters. In order to do so, we developed the first and only in vitro transport assay for the SLC23 family, which enables investigation of protein function in a defined environment. Moreover, we provide a hypothesis on the role of the extremely conserved negative charged substrate binding site residue found not only in the SLC23, but also SLC4 and SLC26 families. Based on a detailed analysis of binding and transport we conclude that this conserved negative charged has a relevance for protein stability rather than for substrate binding, which explains its conservation for all three protein families that otherwise differ in their substrate specificities and modes of transport. Lastly, we investigated the relevance of oligomerization for the SLC23 and SLC26 families, highlighting the importance of the STAS domain for forming active dimers in the SLC26 anion transporter family.
The enzyme 5-lipoxygenase (5-LO) occupies a central role in the biosynthesis of inflammatory leukotrienes and thus takes part in the pathogenesis of related diseases. Its occurrence is mainly restricted to cells of the immune system including granulocytes, monocytes/macrophages or B-lymphocytes and can be induced by cell differentiation of myeloid cells after treatment with differentiating agents, such as DMSO, retinoic acid or the combination of TGFβ/1,25(OH)2D3. The latter contribute to the highest level of induction of mRNA and protein expression. Its cell specific occurrence is at least partly due to DNA methylation in cells that do not exhibit 5-LO activity and genetic regulation is further dependent on histone acetylation. 5-LO expression is controlled by transcription factors binding to the promoter sequence of the ALOX5 gene that induce basal promoter activity, as well as promoter independent effects including transcript initiation and elongation, which are mostly attributed to TGFβ/1,25(OH)2D3 signaling. The ALOX5 gene resembles a typical housekeeping gene, hence lacks TATA- or CAAT-boxes for transcriptional regulation, but displays a high GC-content with eight GC-boxes, five of which are arranged in tandem, that provide binding sites for transcription factors Sp1, Sp3 and Egr-1.
The proximal ALOX5 promoter is furthermore a target for additional factors, such as TGFβ effector proteins SMADs or the vitamin D receptor and possesses additional consensus sequences for transcriptional regulators, including NF-κB or PU.1. However, as yet no actual binding of these proteins to the promoter sequence was demonstrated and an unbiased screening for identifying further ALOX5 promoter interacting proteins, which might have impact on 5-LO expression, is still lacking. For this purpose, the present study focused on the identification of significantly interacting proteins, employing DNA-affinity enrichment coupled to label-free quantitative proteomics, spanning a sequence of about 270 base pairs of the proximal ALOX5 promoter. For the elucidation of potential cell specific differences in protein patterns and compositions, DNA pulldowns were performed by using oligonucleotide stretches comprising the core promoter sequence including the 5-fold GC-box, which were incubated with different cell lines and differentiation states of myeloid, as well as B-lymphocytic lineages. In order to compare different mass spectrometric quantification strategies that would allow for identification of interactors, dimethyl labeling and label-free techniques were used. Since the label-free approach outperformed the label-based one in initial experiments, it was established as standard quantification strategy in all DNA pulldowns performed. The pulldowns of myeloid cell lines in both undifferentiated and differentiated state and B-lymphocytes resulted in a cell-unspecific protein pattern whose composition was similar, regardless of cell lineage. Additionally, further DNA sequences comprising either a vitamin D response element or a SMAD binding element were investigated in the promyelocytic model cell line HL-60 in both undifferentiated and differentiated state. The identified proteins confirmed known interaction partners and furthermore revealed novel potential regulators of the 5-LO promoter. Out of these, the most prominently identified and promising proteins included transcription factors of the KLF- and CCAAT/enhancer binding protein-family. In this context, KLF5 and KLF13 are both involved in the regulation of inflammatory processes, the former additionally being an effector protein of TGFβ-signaling, whose functional characterization is of utmost interest in terms of regulation of 5-LO expression. Further protein characterization will be inevitable for the CCAAT/enhancer binding proteins C/EBPα, C/EBPβ and C/EBPε. These transcription factors are involved in the regulation of inflammatory processes and heterodimers thereof (C/EBPα/β) are known to control TGFβ/1,25(OH)2D3-mediated effects of the CD14 gene.
Several of the identified proteins of the pulldowns containing the tandem GC-box represented interactors of G-quadruplex DNA, including the helicases BLM and DHX36, the ribonucleoproteins hnRNP D and hnRNP K and transcription factor MAZ. Since G-quadruplexes form in G-rich DNA sequences as secondary DNA structures and exhibit substantial regulatory effects on the transcription of their target genes, the potential formation thereof in the ALOX5 core promoter sequence was investigated in a second project. Out of the proteins mentioned above, MAZ is shown to exert resolving effects on G4-DNA and synergistically induce Sp1-dependent gene activation of oncogene h-RAS, which displays analogous promoter characteristics to the ALOX5 gene. A DNA stretch comprising the tandem GC-box was used for elucidating the potential of secondary DNA structure formation. Intriguingly, both immune-based and spectroscopic methods provided clear evidence for the in vitro G-quadruplex formation of the proximal promoter sequence for the first time. In order to provide additional information on a possible regulatory effect of existing G-quadruplex structures on 5-LO transcription, differentiated HL-60 cells were subsequently treated with two distinct G4-DNA stabilizing agents. A porphyrin analogon (TMPyP4) did not exhibit any effects on 5-LO mRNA and protein expression after cell treatment. A second G4-DNA stabilizing agent (pyridostatin) on the other hand revealed significant reduction on 5-LO protein expression after cellular treatment. These mixed results render further experiments inevitable, in order to provide a clear assertion as to whether 5-LO expression is regulated by G-quadruplex structures or not.
Altogether, this study enlarges the knowledge of ALOX5 proximal promoter interacting proteins by corroborating the binding of already known transcription factors and identifying novel interactors. It yields essential groundwork for subsequent functional studies of proteins involved in 5-LO transcription and introduces G-quadruplexes as a new potential mechanism in ALOX5 gene regulation.
Structure-function relationships in substrate binding protein dependent secondary transporters
(2023)
This work provides new insights into the relevance of SBP dependent secondary transport systems, especially in the thus far under-researched subgroup of TAXI transporters. Importantly, we identified and characterized the TAXI transport system TAXIPm-PQM from Proteus mirabilis. We demonstrated that, in contrast to previously characterized SBP dependent secondary transport systems, TAXIPm-PQM is a proton coupled system and transports the C5-dicarboxylate α- ketoglutarate. Since initially the transport of α-ketoglutarate could only be demonstrated in vivo but not in vitro using established protocols (Mulligan et al. 2009), we investigated in detail the differences between the in vivo and in vitro assay. This resulted in a bioinformatic analysis of TRAP and TAXI signal peptides, which strongly implied that TAXIPm-P requires a transmembrane anchor to allow for transport. We then provided TAXIPm-P surface tethered to the membrane in in vitro transport assays and confirmed the prediction of our bioinformatic analysis that TAXIPm-PQM deploys a membrane-anchored instead of a soluble SBP. Furthermore, the TAXI transport system TAXIMh-PQM from Marinobacter hydrocarbonoclasticus transports fumarate only if both membrane domains Q and M are present. For further characterization, Michaelis-Menten kinetics and affinities were determined for both TAXI transport systems TAXIPm-PQM from Proteus mirabilis and TAXIMh-PQM from Marinobacter hydrocarbonoclasticus. In addition, nanobodies were selected for the membrane domain TAXIPm-QM from Proteus mirabilis to stabilize different conformations which can serve in subsequent structural elucidation studies. Furthermore, the TRAP SBP TRAPHi-SiaP from Haemophilus influenzae was shown to interact not only with its corresponding membrane domain TRAPHi-SiaQM but with at least one additional transporter. It was thereby excluded that TRAPHi- SiaP transfers N-acetylneuraminic acid to the only native E. coli TRAP transporter TRAPEc-YiaMNO and suggested to rather interact with a SBP dependent ABC transport system as this protein family represents the largest SBP dependent protein group in E. coli (Moussatova et al. 2008).
The transcriptional regulator RcsB controls the expression of a minimum of 20 different genes having diverse functionalities and biosynthetic operons in the family of Enterobacteriaceae. While in the heterodimeric complex with the co activator RcsA, the RcsAB box consensus is recognized, DNA binding sites for RcsB without RcsA have also been identified. The conformation of RcsB might therefore be modulated upon interaction with various co activators, resulting in recognition of different DNA targets. In this study the interaction of RcsB with some of these DNA targets have been analysed by a diverse array of techniques including gel shift assay and SPR. The solution structure of the C-terminal DNA-binding domain of RcsB from Erwinia amylovora spanning amino acid residues 129-215 has been solved in this study by heteronuclear NMR spectroscopy. The C-terminal domain is composed of four α-helices where the two central helices of the H-T-H motif are similar to the structures of the regulatory proteins GerE, NarL and TraR. The DNA-binding activity of the C-terminal domain alone is established for the first time in this study and was specified by fluorescence spectroscopy, SPR and NMR titration experiments. The molecular interaction between the individual RcsB domains was analysed by cross-linking experiments and heteronuclear NMR spectroscopy and the amino acid residues of the C-terminal domain involved in this interaction were identified precisely. Another important part of this project was the cell-free production of different Trp analogue labelled RcsB protein. RcsB protein was produced in quite a good yield with different Trp analogue having spectrally enhanced properties. The isolated RcsB alloproteins proved to be ideal for protein interaction studies by fluorescence spectroscopy and the very first evidence of an oligomerization of RcsB due to molecular association has been put forth from these studies. The phosphorylated state of the RcsB protein was mimicked by a beryllofluoride complex in order to study its role in transcriptional regulation. It was found that RcsB alone could bind to DNA targets upon this modification by the beryllofluoride complex. Thus the phosphorylation of the protein that involves the Asp 56 residue induces a structural change of the protein followed probably by a domain movement also, so that the C-terminal domain having the H-T-H DNA binding motif that was previously eclipsed by the N-terminal domain is relieved of this constraint.
Salt-inducible kinases (SIKs) are key metabolic regulators. Imbalance of SIK function is associated with the development of diverse cancers, including breast, gastric and ovarian cancer. Chemical tools to clarify the roles of SIK in different diseases are, however, sparse and are generally characterized by poor kinome-wide selectivity. Here, we have adapted the pyrido[2,3-d]pyrimidin-7-one-based PAK inhibitor G-5555 for the targeting of SIK, by exploiting differences in the back-pocket region of these kinases. Optimization was supported by high-resolution crystal structures of G-5555 bound to the known off-targets MST3 and MST4, leading to a chemical probe, MRIA9, with dual SIK/PAK activity and excellent selectivity over other kinases. Furthermore, we show that MRIA9 sensitizes ovarian cancer cells to treatment with the mitotic agent paclitaxel, confirming earlier data from genetic knockdown studies and suggesting a combination therapy with SIK inhibitors and paclitaxel for the treatment of paclitaxel-resistant ovarian cancer.
H/ACA-RNPs are involved in RNA guided pseudouridylation of rRNAs and snRNAs. In this thesis I reconstituted active and labeled archaeal as well as eukaryotic H/ACA-RNPs and studied the structural dynamics of complex assembly and pseudouridine formation. Single molecule FRET spectroscopy was used as method of analysis to study structure, assembly and dynamics of these important complexes.
A method for the ab initio crystal structure determination of organic compounds by a fit to the pair distribution function (PDF), without prior knowledge of lattice parameters and space group, has been developed. The method is called ‘PDF-Global-Fit’ and is implemented by extension of the program FIDEL (fit with deviating lattice parameters). The structure solution is based on a global optimization approach starting from random structural models in selected space groups. No prior indexing of the powder data is needed. The new method requires only the molecular geometry and a carefully determined PDF. The generated random structures are compared with the experimental PDF and ranked by a similarity measure based on cross-correlation functions. The most promising structure candidates are fitted to the experimental PDF data using a restricted simulated annealing structure solution approach within the program TOPAS, followed by a structure refinement against the PDF to identify the correct crystal structure. With the PDF-Global-Fit it is possible to determine the local structure of crystalline and disordered organic materials, as well as to determine the local structure of unindexable powder patterns, such as nanocrystalline samples, by a fit to the PDF. The success of the method is demonstrated using barbituric acid as an example. The crystal structure of barbituric acid form IV solved and refined by the PDF-Global-Fit is in excellent agreement with the published crystal structure data.
Biological membranes serve as physical barriers in cells and organelles, enabling the maintenance of chemical or ionic gradients that are essential for triggering various integral, peripheral, or lipid-anchored membrane proteins, necessary for their life-essential functions. The study of membrane proteins has unique challenges due to their hydrophobic nature, limited expression levels, and inherent flexibility. Single-particle analysis (SPA) enables the determination of high-resolution three-dimensional structures using minimal amounts of specimen without the need for crystallization. Additionally, cryogenic electron tomography (cryo-ET) and subtomogram averaging (StA) offer the ability to study membrane protein complexes, cellular architecture, and molecular interactions while preserving close-to-life conditions. With ongoing improvements in cryo-EM technologies, obtaining high-resolution structures of membrane proteins in vitro can allow people to understand their mechanisms and functions, and to facilitate the design and optimization of new therapeutic agents. Furthermore, there has been significant growth in the structural characterization of membrane proteins in situ, as studying biomolecules within their physiological context is an ultimate goal in structural biology for a comprehensive understanding of molecular networks in cells.
Due to the amphipathic nature of membrane proteins, their production, purification, and isolation pose significant challenges compared to soluble proteins. To maintain the membrane protein fold in an aqueous buffer after disrupting lipid membranes, the use of detergents, amphipols, lipid nanodiscs, saposin-lipoprotein (salipro), styrene-maleic acid co-polymer lipid particles (SMALPS) is common and often essential. A limitation of the membrane-mimetic systems is the absence of an actual lipid bilayer environment. To address this issue, membrane proteins can be reconstituted into liposomes, and this closed membrane environment closely mimics the physiological conditions of the proteins. The use of liposomes for structure determination is expected to significantly expand in the in vitro study of membrane proteins and membrane-associated proteins, particularly for capturing transient complexes in specific functional states.
Resolving the structures of membrane proteins in their native cellular context is considered the ideal approach for understanding their functions and associated molecular networks. While single-particle cryo-EM can achieve higher resolution than subtomogram averaging, it often requires at least partial purification of the target molecules from their native environment inside cells and tissues. By combining averaging tools on subvolumes obtained through cryo-ET, structures can currently be determined at resolutions of 10-30 Å. With ongoing advancements and refinements in cryo-ET methodologies, routine high-resolution structure determination in situ is poised to become a valuable tool for both structural and cell biologists in the long run, and the field holds great promise for further expanding our understanding of cellular structures and processes at the molecular level.
The main aim of this thesis is to further our knowledge of the structure and function of a small prokaryotic voltage-gated sodium ion channel, NaChBac in liposomes, and a large knob complex found on the surface of Plasmodium falciparum-infected human erythrocyte by cryo-ET and StA.
Chapter 2 presents the first StA map of the 120-kDa NaChBac embedded in liposomes under a resting membrane potential at a modest resolution of 16 Å. The approach presented in this study, which can be widely applied to cryo-EM analysis of membrane proteins, with a specific focus on membrane proteins with small soluble domains, lays the foundation for cryo-ET and StA of integral or peripheral membrane proteins whose functions are affected by transmembrane electrochemical gradients and/or membrane curvatures. Chapter 3 shows the first cryo-EM structure of the supramolecular knob complex in P. falciparum-infected human erythrocyte. While a previous study provided an overall architectural view of knobs using negative stain tomography, the in situ structure bridges this gap, guiding future investigations into the molecular composition and the role of these native knobs in Plasmodium infection and immunity.
This thesis opens up several promising lines for future studies of membrane proteins in vitro and in situ, where other membrane proteins can be studied in physiologically relevant environments. Already with the present generation of cryo-EM hardware and software, this thesis represents pioneering research in the field of membrane protein structural biology.
ATP-binding cassette (ABC) transporters constitute an omnipresent superfamily of integral membrane proteins, which catalyze the translocation of a multitude of chemically diverse substrates across biological membranes. In humans, ABC transporters typically act as highly promiscuous exporters, responsible for many physiological processes, multi-drug resistance, and severe diseases, such as hypercholesterolemia, lipid trafficking disorders, and immune deficiency. In all ABC transporters, ATP-driven movements within two highly conserved nucleotide-binding domains (NBDs) are coupled to conformational changes of two transmembrane domains (TMDs), which provide a framework for substrate binding and release on the opposite side of the membrane and enable the transporter to cycle between inward-facing and outward-facing orientations. Several structures of ABC transporters determined either by X-ray crystallography or single-particle electron cryo-microscopy (cryo-EM) have been reported, mostly exhibiting a variation of the inward-facing state, which highlights their dynamic behavior. However, for a complete understanding of the conformational dynamics, further structural information on intermediates is needed – especially for heterodimeric ABC transporters, which are predominant in humans and for which only limited structural information is available.
One prime example of such human heterodimeric ABC transport complexes is the transporter associated with antigen processing (TAP). TAP is a key player of the adaptive immune response, because it translocates proteasomal degradation products into the ER lumen for loading of MHC I molecules. Many functional aspects of TAP have been disclosed in recent years. However, structural information is lacking far behind and a major challenge in the field of medical relevant transporters. Recently, the heterodimeric ABC export system TmrAB (Thermus thermophilus multidrug resistance proteins A and B) was identified as an ortholog of TAP, by sharing structural homology with TAP and, intriguingly, being able to restore antigen presentation in human TAP-deficient cells. Thus, TmrAB is a biochemically well-characterized ABC exporter that can be regarded as a functional ortholog of TAP and serves as a model system for (heterodimeric) ABC export systems in general.
Thus, to illuminate the molecular basis of substrate translocation by single-particle cryo-EM, one of the main objectives of this work was the generation of stabilizing chaperones (synthetic antibodies, nanobodies, cyclic peptides) to reduce the conformational heterogeneity of TAP and TmrAB. Selected antibodies were analyzed with respect to stable complex formation, conformational trapping, and the ability to serve as alignment tools for structural studies by single-particle cryo-EM. Both antibody types were shown to form sufficiently stable complexes to serve as a rigid body for EM analyses. However, all selected antibodies bound to the inward-facing state exclusively.
Hence, for EM studies, various ligands were added to elucidate the full spectrum of conformational states during the catalytic cycle. For TAP, first attempts by negative-stain EM revealed a homogenous distribution of particles on the grid. Surprisingly, no transporter-like features were observed although various attempts were applied to increase the overall sample quality.
For TmrAB, in contrast, the complete conformational space in a native-like lipid environment under turnover conditions was mapped. Cryo-EM analysis of TmrAB incubated with ATP-Mg2+ and substrate revealed two distinct inward-facing conformations (IFwide and IFnarrow) as well as two asymmetric conformations with dimerized NBDs, which were markedly different from all previously reported structures. Here, the catalytically active site was slightly wider and contained ADP, while ATP was still bound at the catalytically-inactive site within the NBDs, demonstrating an asymmetric post-hydrolysis state. Intriguingly for the inward-facing conformations, a weak additional density close to residues M139TmrB and W297TmrB was observed in the inward-facing conformation, which displayed a higher degree of cytosolic gate opening (IFwide) indicating the presence of substrate. To verify that this density corresponds to substrate, single alanine mutations of M139TmrB and W297TmrB were introduced, leading to a strong reduction in substrate binding and transport. Since substrate release requires the opening of the extracellular gate, the absence of an outward-facing open conformation indicated that the opening must be highly transient. In order to explore the outward-facing open conformation, a cryo-EM analysis of the catalytically-inactive TmrAE523QB mutant upon incubation with ATP-Mg2+ was performed. Remarkably, within the same dataset, two different outward-facing conformations (occluded and open) were resolved, both in an ATP-bound state, which indicated that binding of ATP is sufficient to drive the large-scale conformational transition from inward-facing to outward-facing open. To explore the effect of nucleotide hydrolysis, TmrAB was trapped by vanadate. Again, two populations were observed, representing the outward-facing open and outward-facing occluded conformation.
Based on several structures of key intermediates, determined under turnover conditions or trapped in the pre-hydrolysis and hydrolysis transition state, for the first time the complete description of the ATP hydrolysis and translocation cycle of a heterodimeric ABC transport complex was elucidated in one single study. By mapping the conformational landscape during active turnover, aided by mutational and chemical modulation of kinetic rates, fundamental and so-far hidden steps of the substrate translocation cycle of asymmetric ABC transporters were resolved and a general template for (heterodimeric) ABC exporter-catalyzed substrate translocation was provided.
Dysfunction of YEATS-domain-containing MLLT1, an acetyl/acyl-lysine dependent epigenetic reader domain, has been implicated in the development of aggressive cancers. Mutations in the YEATS domain have been recently reported as a cause of MLLT1 aberrant reader function. However, structural basis for the reported alterations in affinity for acetyled/acylated histone has remained elusive. Here, we report the crystal structures of both insertion and substitution present in cancer, revealing significant conformational changes of the YEATS-domain loop 8. Structural comparison demonstrates that such alteration not only altered the binding interface for acetylated/acylated histones, but the sequence alterations in the T1 loop may enable dimeric assembly consistent inducing self-association behavior. Nevertheless, we show that also the MLLT1 mutants can be targeted by developed acetyllysine mimetic inhibitors with affinities similarly to wild type. Our report provides a structural basis for the altered behaviors and potential strategy for targeting oncogenic MLLT1 mutants.
In this thesis, we characterized megasynthases such as fatty acid synthases (FASs) and polyketide synthases. The obtained insights into structure and function were used to engineer such systems to produce new-to-nature compounds.
The in vitro characterization of megasynthases requires reproducible access to these enzymes in high quality. Therefore, we established purification strategies for the yeast FAS and the methylsalicylic acid synthase (MSAS) from Saccharopolyspora erythraea (SerMSAS) and applied the latter one on MSAS from Penicillium patulum (PenPaMSAS) and on 6-deoxyerythronolide B synthase (DEBS) module 6. With the purified samples, we were able to obtain initial structural data for SerMSAS and solve the complete structure of the yeast FAS (PDB: 6TA1). On the example of the yeast FAS, we could show that the sample can suffer from adsorption to the water-air interface during the grid preparation for electron microscopy and presented how the use of graphene-based grids can overcome this problem. The combined structural and functional analysis of the yeast FAS showed that the structural domains trimerization module and dimerization module 2 are not essential for the assembly of the whole system. Therefore, they can potentially be used for domain exchange approaches. The in-depth functional analysis of SerMSAS revealed that not SerMSAS itself releases the product, but a 3-oxoacyl-(acyl-carrier protein) synthase like enzyme within the gene cluster transfers 6-methyl salicylic acid from SerMSAS to another carrier protein for subsequent modifications. In contrast, we showed that PenPaMSAS can release its product by hydrolysis and that non-native substrates can be incorporated although at significantly slower turnover rates compared to the native starter substrate. Our further investigation demonstrated that the substrate specificity of the acyltransferase (AT) is a critical factor for the incorporation of non-native substrates.
With the insight from the functional and structural characterization, we engineered megasynthases for the biosynthesis of natural product derivatives. We targeted the AT of PenPaMSAS for active site mutagenesis and discovered a mutant which can transfer non-native substrates significantly faster (~200-300%). Additionally, the malonyl/acetyl transferase (MAT) of the mammalian FAS was used as a promising target for protein engineering because of its previously reported properties including polyspecificity, fast transfer kinetics, robustness, and plasticity. We showed that the MAT can transfer fluorinated substrates and accept the acyl carrier protein of DEBS module 6. By exchanging the substrate specific AT of DEBS with the polyspecific MAT of the mammalian FAS, we demonstrated an efficient DEBS/FAS hybrid and an optimal truncation site for the applied ATs. In contrast to the wild type system, the DEBS/FAS enzyme was able to synthesize demethylated and fluorinated derivatives. The production and purification of a fluoro-methyl-disubstituted polyketide was of particular interest, as it has a high potential for the generation of new drugs and shows the potential of protein engineering. Furthermore, the incorporation of the disubstituted substrate had important implication in the mechanistic details of the ketosynthase-mediated C-C bond formation.
Während meiner Promotion habe ich zwei Projekte unter der Aufsicht von Dr. Misha Kudryashev durchgeführt. Im ersten Projekt habe ich die Strukturen des Ryanodinrezeptors 1 (RyR1) in Apo- und Ryanodin-Bindungszuständen in der nativen Membran durch Tomographie und Subtomogramm-Mittelung bei 12,6 bzw. 17,5 Å bestimmt. Im Vergleich zur Struktur von gereinigtem RyR1 unter Verwendung der Einzelpartikel-Kryo-Elektronenmikroskopie (Cryo-EM) können zusätzliche Dichten in der cytoplasmatischen Domäne und der sarkoplasmatischen Retikulum (SR)-Membran bzw. im SR-Lumen beobachtet werden. Die Auflösung der Struktur von RyR1 im Apo-Zustand wurde von den Kollegen in meinem Labor mithilfe der Hybridmethode auf 9,5 Å verbessert. Diese Arbeit hat unser Verständnis für die Mechanismen von RyR1 in nativen Membranen erweitert. Im zweiten Projekt habe ich die Struktur des Proteins SdeC der SidE-Familie durch Einzelpartikel-Kryo-EM bei 4,6 Å bestimmt. Die Kristallstruktur des C-Terminus von SdeA wurde von meinem Forschungspartner Dr. Mohit Misra gelöst. Durch Überlagerung einer gemeinsamen Helix dieser beiden Strukturen konnten wir ein kombiniertes Modell erstellen und ein allgemeines Verständnis der Proteine der SidE-Familie erhalten.
To evade the host's immune response, herpes simplex virus employs the immediate early gene product ICP47 (IE12) to suppress antigen presentation to cytotoxic T-lymphocytes by inhibition of the ATP-binding cassette transporter associated with antigen processing (TAP). ICP47 is a membrane-associated protein adopting an alpha-helical conformation. Its active domain was mapped to residues 3-34 and shown to encode all functional properties of the full-length protein. The active domain of ICP47 was reconstituted into oriented phospholipid bilayers and studied by proton-decoupled 15N and 2H solid-state NMR spectroscopy. In phospholipid bilayers, the protein adopts a helix-loop-helix structure, where the average tilt angle of the helices relative to the membrane surface is approximately 15 degrees (+/- 7 degrees ). The alignment of both structured domains exhibits a mosaic spread of approximately 10 degrees . A flexible dynamic loop encompassing residues 17 and 18 separates the two helices. Refinement of the experimental data indicates that helix 1 inserts more deeply into the membrane. These novel insights into the structure of ICP47 represent an important step toward a molecular understanding of the immune evasion mechanism of herpes simplex virus and are instrumental for the design of new therapeutics.
The post-transcriptional modification of the canonical nucleoside uridine into its rotational isomer pseudouridine occurs in non-coding as well as coding RNA and is the most abundant post-transcriptional modification in all kingdoms of life. While the occurrence of pseudouridine has been linked to the enhancement of stability and the codon-anticodon interaction in tRNAs, enhancement of the translation efficiency in rRNAs, regulatory functions in spliceosomal snRNA and nonsense codon suppression in mRNA, its exact role in many RNAs is still ambiguous. The uridine to pseudouridine isomerization can either be catalyzed by one of various standalone pseudouridylases or it can be performed in an RNA-guided manner by H/ACA ribonucleoproteins. In eukaryotes, the guide RNA always adapts a conserved bipartite, double-hairpin conformation. Each hairpin contains an internal RNA-loop motif, which can recruit a specific substrate RNA via base pairing. The catalytically active RNP is formed by the interactions of the guide RNA with four proteins. While Cbf5 forms the catalytically active center, Nop10 and Nhp2 perform auxiliary functions and Gar1 is involved in substrate turnover. Up until now, most structural knowledge about H/ACA RNPs has been derived from archaeal complexes, while the exact structure-function-relationships between RNA and proteins in eukaryotic RNPs is still ambiguous. While archaeal H/ACA RNPs share many similarities with eukaryotic RNPs and act as good model system, there are also many differences between them like eukaryotic specific protein domains as well as the overall bipartite complex structure, dictated by the snoRNA. Investigating pseudouridylation by eukaryotic H/ACA RNPs opens up a broad area of research and helps to gain a better understanding of this enzyme class – especially since malfunction of H/ACA RNPs has been linked to the genetic disease Dyskeratosis congenita as well as several types of cancer.
The main goal of this thesis was to gain new insights into the RNA/protein interactions in the eukaryotic snR81 H/ACA snoRNP from Saccharomyces cerevisiae on a structural as well as dynamical level. In the first part of this thesis, the main goal was to in vitro prepare a functionally active snR81 H/ACA RNP. The guiding snoRNA was prepared by in vitro transcription and purification, while the Saccharomyces cerevisiae proteins were recombinantly expressed from Escherichia coli. Apart from the full length, bipartite snR81 snoRNP, several sub-complexes of the RNP were reconstituted. Therefore, snoRNA constructs were designed and prepared, which only contained a single hairpin motif of the complex. Furthermore, snoRNA constructs in which the apical hairpin stem was replaced by a stable tetraloop were prepared, to investigate the influence of the apical stem on protein binding and activity. Also, for the eukaryotic proteins, a shortened version of Gar1 (Gar1Δ) was utilized, which lacks the eukaryotic specific RGG domains, that have been characterized as accessory RNA binding motifs. Reconstituted snoRNPs were utilized in catalytic activity assays, monitoring the turnover rate of uridine to pseudouridine. For this purpose, radioactively labeled substrate RNAs were prepared by phosphorylation and splinted ligation of oligonucleotides and were objected to reconstituted H/ACA RNPs under single as well as multiple turnover conditions. In the second part of this thesis, the RNA/protein interactions were dissected via single molecule FRET spectroscopy. Therefore, the snoRNA was labeled with an acceptor fluorophore via NHS ester/amine-reaction. Furthermore, the snoRNA contained a biotin-handle, allowing immobilization of the complex during the experimental time-window of the spectroscopic analysis. Eukaryotic specific protein Nhp2 was labeled with a donor fluorophore via “click” chemistry, which included the chemical synthesis and incorporation by genetic code expansion of non-canonical amino acids. The interactions of Nhp2 with the different snoRNA constructs (standalone-hairpins “H5” and “H3”, as well as hairpins lacking the apical binding motif “H5Δ” and “H3Δ”) were monitored on a single molecule level.
In summary, it was possible to gain new insights into the complex structure and the dynamical behavior of the still sparsely characterized eukaryotic H/ACA RNPs. Especially, new knowledge could be obtained about the hairpin specific behavior on the bipartite RNA complex structure, including the rather ambiguous role of the protein Nhp2 and the contribution of the eukaryotic specific features of Gar1 in their interaction with the guide/substrate RNA.
Human protein kinases play essential roles in cellular signaling pathways and - if deregulated - are linked to a large diversity of diseases such as cancer and inflammation or to metabolic diseases. Because of their key role in disease development or progression, kinases have developed into major drug targets resulting in the approval of 52 kinase inhibitors by the Food and Drug Administration (FDA) so far.
Within the drug discovery process, the affinity of the inhibitors is the parameter that is used most often to predict the later efficacy in humans. However, the kinetics of binding have recently emerged as an important but largely neglected factor of kinase inhibitor efficacy. To efficiently suppress a signaling pathway, the targeted kinase needs to be continuously inhibited. Thus, it has been hypothesized that fast binding on-rates and slow off-rates would be the preferred property of an efficacious inhibitor. Despite optimizing the potency of kinase inhibitors, in the past decade optimization of kinetic selectivity has therefore gained interest as a molecule cannot be active unless it is bound, as Paul Ehrlich once stated. There is increasing evidence of correlations between prolonged drug-target residence time and increased drug efficacy, and that inhibitor selectivity in cellular contexts can be modulated by altered residence times. In order to contribute to the understanding of the effect of long residence times on cellular targets we initiated two projects.
The first of these projects is related to the STE20 kinase Serine/threonine kinase 10 (STK10) and its close relative STE20 like kinase (SLK) which have been reported to be frequent off-targets for kinase inhibitors used in the clinics. Also, an inhibition of STK10 and SLK has been linked to a common side-effect of severe skin rash developed upon treatment with the EGFR inhibitor erlotinib, but not gefitinib and the severity of this rash correlated with the treatment outcome, which fits the known biology of STK10 and SLK to be regulators of lymphocyte migration and PLK kinases. However, there are yet no explanations why these two proteins show such high hit-rates across the kinome among the kinase inhibitors. Using structural analysis, we identified the flexibility of STK10 to be the main reason for this hit-rate. The observed strong in vitro potencies did however not translate to the cellular system which is why we investigated the inhibitors residence time on STK10. We found the same flexibility to be the main reason for slow residence times among several inhibitors. We observed large rearrangements in the hydrophobic backpocket of STK10 including the αC, the P-loop enclosing the inhibitor like a lid and strong π-π-stackings to be the main reasons for prolonged residence times on STK10. Interestingly, we observed an increased residence time for erlotinib, which showed skin-related side-effects, giving rise whether the binding kinetics should be investigated for weak cellular off-target effects in future drug discovery efforts.
In the second project we initiated, we illuminate a structural mechanism that allows kinetic selection between two closely related kinases, focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK2). Using an inhibitor series designed to probe the mechanism, residence times measured in vitro and in cells showed a strong correlation. Crystal structures and mutagenesis identified hydrophobic interactions with L567, adjacent to the DFG-motif, as being crucial to kinetic selectivity of FAK over PYK2. This specific interaction was observed only when the DFG-motif was stabilized into a helical conformation upon ligand binding to FAK. The interplay between the protein structural mobility and ligand-induced effect was found to be the key regulator of kinetic inhibitor selectivity for FAK over PYK2.
These two projects showed that the parameter residence time should be considered for different problems among the drug discovery process. First, in an open in vivo system not only the potency of a drug alone, but as well its residence time might be of importance. Here we showed that the weak cellular potency translated to prolonged residence times for several inhibitors in cells and established a link between the phenotypic outcome of skin rash after erlotinib treatment and the residence time of this inhibitor on STK10 in cells. On the other hand, medicinal chemistry efforts should consider structure kinetic relationships (SKR) in the optimization process and aim to understand the molecular basis for prolonged target residence times. Here, we showed that a hydrophobic interaction that is enforced upon inhibitor binding is crucial for an unusual helical DFG conformation which arrests the inhibitor and prolongs its residence time providing the molecular basis for understanding the kinetic selectivity of two closely related protein kinases. Establishing the SKRs will help medicinal chemists to kinetically optimize their drug candidates to select a suitable molecule to proceed into further optimization programs. Hence, the projects showed that the target residence time parameter needs to be considered both as a molecular optimization parameter to improve compound potency and binding behavior as well as a parameter to be understood for proceeding to the open system of in vivo models to later modulate the in vivo efficacy of protein kinase targeting drugs.
The endoplasmic-reticulum-associated protein degradation pathway ensures quality control of newly synthesized soluble and membrane proteins of the secretory pathway. Proteins failing to fold into their native structure are processed in a multistep process and finally ubiquitinated and degraded by the proteasome in order to protect the cell from proteotoxic stress. My thesis covers structural as well as functional studies of various protein components that constitute the protein complexes that are responsible for this process.
One sub-project addressed the mechanism of glycan recognition by Yos9 as part of the ERAD substrate selection. NMR solution structures of the mannose-6-phosphate homology (MRH) domain of Yos9 both in a free and glycan bound conformation reveal a gripping movement of loop regions upon binding of correctly processed glycan structures.
The main projects focused on revealing the mechanism of efficient ubiquitin chain assembly by the ERAD ubiquitination machinery. This included the investigation of the role of the ERAD components Cue1 and Ubc7 in processive ubiquitin chain formation, how ubiquitin chain conformations change during elongation, how the conformation of a chain is impacted by interacting proteins and finally understand the activity regulation of the ERAD E2 enzyme Ubc7 by its cognate RING E3 ligases. Nuclear magnetic resonance (NMR) analysis and fluorescence-based ubiquitination assays show that the CUE domain of Cue1 contributes with its proximal binding preference as well as with its position dependent accelerating effect to efficient ubiquitin chain formation. This is required to efficiently drive degradation of substrates. Specific ubiquitin binding events dictate and coordinate the spatial arrangement of the E2 enzyme relative to the distal tip of a chain. This process can be further accelerated by RING E3 ligases that promote Ubc7 activity by more than ~20 fold via inducing allosteric changes around the catalytic cysteine. My results additionally suggest a model where Ubc7 dimerization results in proximity induced activation of the E2. This data ensures rapid diubiquitin formation that is followed by a CUE domain assisted chain elongation mechanism where Cue1 acts in an E4 like fashion.
How ubiquitin binding events can modulate the conformations of a ubiquitin chain were investigated by pulsed electron-electron double resonance (PELDOR) spectroscopy combined with molecular modeling. This shows that K48-linked diubiquitin samples a broad conformational space which can be modulated in distinct ways. The CUE domain of Cue1 uses conformational selection of pre-populated open conformations to support ubiquitin chain elongation. In contrast, deubiquitinating enzymes shift the conformational distribution to weakly or even non-populated conformations to allow cleavage of the isopeptide bond that connects adjacent ubiquitins. Ubiquitin chain elongation increases the sampled conformational space and suggests that this high conformational flexibility might contribute to efficient proteasomal recognition.
Signal transduction via phosphorylated CheY towards the flagellum and the archaellum involves a conserved mechanism of CheY phosphorylation and subsequent conformational changes within CheY. This mechanism is conserved among bacteria and archaea, despite substantial differences in the composition and architecture of archaellum and flagellum, respectively. Phosphorylated CheY has higher affinity towards the bacterial C-ring and its binding leads to conformational changes in the flagellar motor and subsequent rotational switching of the flagellum. In archaea, the adaptor protein CheF resides at the cytoplasmic face of the archaeal C-ring formed by the proteins ArlCDE and interacts with phosphorylated CheY. While the mechanism of CheY binding to the C-ring is well-studied in bacteria, the role of CheF in archaea remains enigmatic and mechanistic insights are absent. Here, we have determined the atomic structures of CheF alone and in complex with activated CheY by X-ray crystallography. CheF forms an elongated dimer with a twisted architecture. We show that CheY binds to the C-terminal tail domain of CheF leading to slight conformational changes within CheF. Our structural, biochemical and genetic analyses reveal the mechanistic basis for CheY binding to CheF and allow us to propose a model for rotational switching of the archaellum.
Cytochrome c oxidases are among the most important and fundamental enzymes of life. Integrated into membranes they use four electrons from cytochrome c molecules to reduce molecular oxygen (dioxygen) to water. Their catalytic cycle has been considered to start with the oxidized form. Subsequent electron transfers lead to the E-state, the R-state (which binds oxygen), the P-state (with an already split dioxygen bond), the F-state and the O-state again. Here, we determined structures of up to 1.9 Å resolution of these intermediates by single particle cryo-EM. Our results suggest that in the O-state the active site contains a peroxide dianion and in the P-state possibly an intact dioxygen molecule, the F-state may contain a superoxide anion.
The nsP3 macrodomain is a conserved protein interaction module that plays essential regulatory roles in host immune response by recognizing and removing posttranslational ADP-ribosylation sites during SARS-CoV-2 infection. Thus, targeting this protein domain may offer a therapeutic strategy to combat the current and future virus pandemics. To assist inhibitor development efforts, we report here a comprehensive set of macrodomain crystal structures complexed with diverse naturally-occurring nucleotides, small molecules as well as nucleotide analogues including GS-441524 and its phosphorylated analogue, active metabolites of remdesivir. The presented data strengthen our understanding of the SARS-CoV-2 macrodomain structural plasticity and it provides chemical starting points for future inhibitor development.
YEATS-domain-containing MLLT1 is an acetyl/acyl-lysine reader domain, which is structurally distinct from well-studied bromodomains and has been strongly associated in development of cancer. Here, we characterized piperazine-urea derivatives as an acetyl/acyl-lysine mimetic moiety for MLLT1. Crystal structures revealed distinct interaction mechanisms of this chemotype compared to the recently described benzimidazole-amide based inhibitors, exploiting different binding pockets within the protein. Thus, the piperazine-urea scaffold offers an alternative strategy for targeting the YEATS domain family.
N6-methyladenosine (m6A) is the most abundant and well understood modification in eukaryotic mRNA and was first identified in polyadenylated parts of the mRNA.The distinct distribution of m6A in the transcriptome with special enrichment in long internal exons, 39UTRs and around stop codons was uncovered by early biochemical work and later on antibody based sequencing techniques. The so called m6A writer, reader and eraser machinery is responsible for the dynamic and with that regulatory nature of the m6A modification. As m6A writer, the human N6-methyltransferase complex (MTC) cotranscriptionally methylates the central adenine within a RRACH (preferably GGACU) sequence context to form m6A in the nascent RNA chain.9–15 The catalytic core of the complex is formed by the two proteins METTL3 and METTL14, with the active site located in the methyltransferase domain (MTD) of METTL3.16–18 The DPPW motif near the methyl donor S-adenosylmethionine (SAM) binding site in this MTD was postulated to bind the target adenine during catalysis. Moreover, a positively charged groove in the METTL3-METTL14 interface, the C-terminal RGG domain in METTL14 and the zinc finger motifs in METTL3 were identified as important domains for RNA binding. However, to date there are no full-length or substrate-RNA-bound structures of the catalytic METTL3-METTL14 complex.
In addition, a set of accessory proteins assembles to the METTL3-METTL14 heterodimer to form the full MTC, mediated by WTAP that firmly binds to the N-terminal leader helix in METTL3.20 WTAP was shown to locate the whole complex to the nuclear speckles and can modulate m6A deposition to specific sites in the RNA. Moreover, WTAP acts as binding platform for other accessory proteins including VIRMA, RBM15, ZC3H13 and HAKAI that are mostly identified to mediate position specific methylation. For example, RBM15 was shown to mediates region-selective methylation in a WTAP dependent manner, directing specificity towards U-rich sequences.
The observed specificity of the methyltransferase complex to methylate only site specific DRACH sequenced is still poorly understood. Some possible modulators like the role of the accessory proteins are under investigation, however, the structural context of the RNA methylation sites or a structural preference of the complex have been mainly neglected so far. Moreover, the structural dynamics of this methylation process still remain elusive. This thesis contributes to the afore-mentioned aspects by analysis of the methylation process regarding RNA structure sensitivity with enzymatic activity assays and its dynamic nature by implementing a smFRET approach.
We hypothesized the target RNA secondary structure to be an additional important modulator of methylation efficiency, based on the RNA binding elements of the complex (positively charged binding groove, zinc finger domain, RGG domain) and the supposed target adenine binding in the active site. Here, we postulated the possibility for a flipped-out adenine to be of special relevance, which is closely related to the local stability of the target adenine containing structure. Moreover, efficient binding of the protein complex to the RNA should require the ability to anchor the RNA on both sides of the target sequence.
Die vorliegende Dissertation mit dem Titel “Structural dynamics of eukaryotic H/ACA RNPs from Saccharomyces cerevisiae & Structural dynamics of the Guanidine-II riboswitch from Escherichia coli” besteht aus zwei Projekten. Das erste Projekt befasst sich mit den eukaryotischen H/ACA Ribonukleoproteinen (RNP) aus der Hefe. Diese können sequenzspezifisch in der RNA ein Uridin Nukleotid in das Rotationsisomer Pseudouridin (Ψ) umwandeln. Die H/ACA RNPs bestehen aus einer Leit-RNA und vier Proteinen, der katalytisch aktiven Pseudouridylase Cbf5, Nhp2, Gar1 und Nop10. Die Leit-RNA besteht in Eukaryoten konserviert aus zwei Haarnadelstrukturen, die von einem H-Box oder ACA-Box Sequenzmotiv gefolgt sind. In jeder dieser Haarnadeln befindet sich ein ungepaarter Bereich, die sogenannte Pseudouridylierungstasche, wo durch komplementäre Basenpaarung die Ziel-RNA gebunden wird. Fehlerhafte H/ACA RNPs können beim Menschen zu schweren Krankheiten wie verschiedenen Krebsarten oder dem Knochenmarksversagen Dyskeratosis congenita führen, aber sie bieten auch Möglichkeiten zum Einsatz als Therapiemethode. In dieser Arbeit wurde hauptsächlich der zweiteilige Aufbau der H/ACA RNPs untersucht.
Dafür wurden zunächst die einzelnen Komponenten hergestellt werden. Cbf5, Nop10 und Gar1 wurden zusammen heterolog in E. coli exprimiert und gereinigt. Außerdem wurden mehrere Deletionsvarianten von Gar1 hergestellt. Zusätzlich wurde die Leit-RNA unmarkiert über T7 Transkription synthetisiert, sowie sechs verschiedene FRET-Konstrukte mit verschiedenen Markierungschemas der Fluorophore Cy3 und Cy5 über DNA-geschiente Ligation. Anschließend wurde über Größenausschlusschromatographie und radioaktiven Aktivitätsassays geprüft, dass sich die aktiven H/ACA RNPs in vitro aus den einzelnen Komponenten rekonstituieren lassen.
In smFRET Experimenten wurden einzelne Haarnadelstrukturen mit dem zweiteiligen Komplexen verglichen. Dabei konnte gezeigt werden, dass die H3 Haarnadel durch die Anwesenheit von H5 dynamischer und heterogener wurde, während H5 überwiegend unbeeinflusst war. Außerdem konnte die dreidimensionale Orientierung der Haarnadelstrukturen in verschiedenen Assemblierungsschritten mittels smFRET untersucht werden. Hier deutete sich an, dass in Abwesenheit von Proteinen beide Haarnadeln eher entgegengesetzt stehen als in einer parallelen Konformation. Cbf5 scheint den Linker zwischen den Beiden auszustrecken bzw. zu orientieren und die Haarnadelstrukturen etwas gegeneinander zu neigen. Ein Zusammenspiel von Nhp2 und Gar1 war nötig um die oberen Bereiche der Haarnadeln zusammenzuziehen. Es konnte auch ein Modell für den vollen H/ACA RNP vorgeschlagen werden. Im kompletten Komplex könnte das Zusammenziehen der Haarnadelstrukturen durch Nhp2 und Gar1 mit dem Effekt von Cbf5 konkurrieren und könnte hauptsächlich den oberen Bereich von H3 betreffen. Zum Schluss wurde das Zusammenspiel von Gar1 und Nhp2 auf eine Abhängigkeit von den RGG Domänen von Gar1 hin untersucht. Hier besteht möglicherweise eine Hierarchie, die eine Kooperativität von den N- und C-terminalen Domänen benötigt.
Das zweite Projekt befasst sich mit dem Guanidin-II Riboschalter aus E. coli. Der Riboschalter kann das toxische Molekül Guanidinium (Gdm+) spezifisch in seiner Aptamerdomäne binden und dadurch die Genexpression von Proteinen zur Detoxifizierung von Gdm+ aktivieren. Der Riboschalter besteht aus zwei Haarnadelstrukturen, mit einer Schleife, die aus der Sequenz ACGR besteht, wobei R ein Purin ist. In einem vorgeschlagenen Modell soll die Ribosomenbindestelle (Shine-Dalgarno Sequenz) in Abwesenheit von Ligand mit dem Linker komplementär Basenpaaren und so die Translation verhindern. Mit Ligand würde sich dann eine Schleifen-Schleifen Interaktion mit den beiden CG Basen ausbilden, wodurch die Anti-Shine-Dalgarno Sequenz nicht mehr zugänglich wäre. Bisherige Studien arbeiteten zumeist nur mit der Aptamerdomäne, den einzelnen Haarnadeln oder noch kleineren Elementen. In dieser Arbeit wurden die Strukturdynamiken von verschiedenen Längen, auch mit der Expressionsplatform, untersucht. Außerdem wurden verschiedene Mutationen analysiert und die Effekte auf den Riboschalter in seiner natürlichen Umgebung in E. coli.
Zunächst mussten insgesamt 24 FRET-Konstrukte hergestellt werden, die sich in Länge, Markierungsschema und Mutationen unterschieden. Hierfür wurde DNA-geschiente Ligation verwendet. Dank der verschiedenen Fluorophorpositionen konnte ein konformationelles Modell für die Aptamerdomäne vorgeschlagen werden. In diesem Modell könnte in Abwesenheit von Ionen das Aptamer offen vorliegen. Durch Mg2+ würde sich bereits eine lockere Schleifen-Schleifen Interaktion ausbilden. Zusätzlich deuten die Ergebnisse auf eine neue Konformation hin, der stabilisierten Schleifen-Schleifen Interaktion, bei der der Linker zusätzlich mit den Haarnadelstrukturen interagiert, beispielswese mit den Purinen an der vierten Schleifenposition...
The p53 protein family is the most studied protein family of all. Sequence analysis and structure determination have revealed a high
similarity of crucial domains between p53, p63 and p73. Functional studies, however, have shown a wide variety of different tasks in
tumor suppression, quality control and development. Here we review the structure and organization of the individual domains of
p63 and p73, the interaction of these domains in the context of full-length proteins and discuss the evolutionary origin of this
protein family.
FACTS:
● Distinct physiological roles/functions are performed by specific isoforms.
● The non-divided transactivation domain of p63 has a constitutively high activity while the transactivation domains of p53/p73
are divided into two subdomains that are regulated by phosphorylation.
● Mdm2 binds to all three family members but ubiquitinates only p53.
● TAp63α forms an autoinhibited dimeric state while all other vertebrate p53 family isoforms are constitutively tetrameric.
● The oligomerization domain of p63 and p73 contain an additional helix that is necessary for stabilizing the tetrameric states.
During evolution this helix got lost independently in different phylogenetic branches, while the DNA binding domain became
destabilized and the transactivation domain split into two subdomains.
OPEN QUESTIONS:
● Is the autoinhibitory mechanism of mammalian TAp63α conserved in p53 proteins of invertebrates that have the same function
of genomic quality control in germ cells?
● What is the physiological function of the p63/p73 SAM domains?
● Do the short isoforms of p63 and p73 have physiological functions?
● What are the roles of the N-terminal elongated TAp63 isoforms, TA* and GTA?
Electron microscopy (EM) demarcates itself from other structural biology techniques by its applicability to a large range of biological objects that spans from whole cells to individual macromolecules. In single-particle cryo-EM, frozen-hydrated samples, prepared by vitrification with liquid ethane, retain macromolecules in a medium that approximates their natural aqueous environment and that, in this way, preserves high-resolution structural information. Nonetheless, the sensitivity of biological specimens to the high-energy electron beam introduces restrictions on the total dose that can be used during imaging while avoiding significant radiation damage. Consequently, the signal-to-noise ratio attained in each individual image is very low, and structures with high-resolution detail must be recovered by averaging thousands of projections in random orientations. This is achieved through the use of image processing algorithms capable of aligning and classifying particle images through the evaluation of cross-correlation functions between each particle and a reference.
In recent years, several innovations took place in the field of single-particle cryo-EM, among which the development of direct electron detectors must be highlighted. Direct electron detectors have a better detective quantum efficiency (DQE) than both photographic film and CCD cameras, and offer a fast readout, compatible with the acquisition of movie stacks. Additionally, new image processing software has become available, with more sophisticated algorithms and designed to take advantage of the specific characteristics of the movies produced with direct electron detectors. These technological advances in both hardware and software catalyzed a revolution in single-particle cryo-EM, which is now routinely used for the determination of near-atomic structures. As a result, the range of macromolecules accessible to cryo-EM has increased drastically, as targets that were unsuitable before for imaging due to their small dimensions can now be adequately visualized and refined to high-resolution.
During my doctoral work, I have used single-particle cryo-EM to structurally characterize challenging membrane proteins, with a strong emphasis on protein complexes from aerobic respiratory chains. In chapter I of this thesis, I present my results on the bovine respirasome, a mitochondrial supercomplex composed of complexes I, III and IV. Chapter II is dedicated to the analysis of the structure of alternative complex III (ACIII) from Rhodothermus marinus, a bacterial quinol:cytochrome c/HiPIP oxidoreductase unrelated to the canonical cytochrome bc1 complex (complex III). In addition, in chapter III I describe the structure of KimA, a high-affinity potassium transporter that drives the transport of its substrate by using the energy stored in the form of a proton gradient. These three membrane proteins, with molecular weights ranging from 140 kDa to 1.7 MDa, illustrate the possibilities and limitations faced in single-particle cryo-EM.
The aerobic respiratory chain is responsible for the generation of a transmembrane difference of electrochemical potential that is then used by ATP synthase for the production of ATP or for driving solute transport over the membrane. They catalyze the transfer of electrons from a substrate, such as NADH or succinate, to molecular oxygen and use the chemical energy released in these redox reactions to drive the translocation of protons, or in some cases sodium ions, to the intermembrane space in mitochondria or the periplasm in bacteria.
In mitochondria, the respiratory chain is composed of four complexes: complex I (NADH:ubiquinone oxidoreductase), complex II (succinate dehydrogenase), complex III (cytochrome bc1 complex) and complex IV (cytochrome c oxidase). While it was for a long time believed that these complexes existed as single entities in the membrane, the use of milder procedures for protein purification and analysis revealed that respiratory complexes associate into well-ordered structures, known as supercomplexes. These have been proposed to offer different structural and functional advantages that are still controversial, including substrate channeling, stabilization of individual complexes and reduction of reactive oxygen species (ROS) production. The most thoroughly studied respiratory supercomplex has been the respirasome, conserved in higher eukaryotes and composed of one copy of complex I, a complex III dimer and one complex IV. By single-particle cryo-EM analysis, I retrieved a 9 Å map of the respirasome from Bos taurus, which allowed the accurate docking of atomic models of the three component complexes. The structure shows that complex III associates to the concave side of the membrane arm of complex I, while complex IV is located between the end of the complex I hydrophobic arm and complex III. Several defined protein-protein contacts are observed between the component complexes, which are mediated predominantly by supernumerary subunits and close to the membrane surfaces. The interactions established between complex I and complex III are extensive and may support the argument that the association of complex I into supercomplexes is required for the stabilization or even the biogenesis of this complex.
...
The heterotetrameric human transfer RNA (tRNA) splicing endonuclease (TSEN) catalyzes the excision of intronic sequences from precursor tRNAs (pre-tRNAs)1. Mutations in TSEN and its associated RNA kinase CLP1 are linked to the neurodegenerative disease pontocerebellar hypoplasia (PCH)2–8. The three-dimensional (3D) assembly of TSEN/CLP1, the mechanism of substrate recognition, and the molecular details of PCH-associated mutations are not fully understood. Here, we present cryo-electron microscopy structures of human TSEN with intron-containing pre-tRNATyrgta and pre-tRNAArgtct. TSEN exhibits broad structural homology to archaeal endonucleases9 but has evolved additional regulatory elements that are involved in handling and positioning substrate RNA. Essential catalytic residues of subunit TSEN34 are organized for the 3’ splice site which emerges from a bulge-helix configuration. The triple-nucleotide bulge at the intron/3’-exon boundary is stabilized by an arginine tweezer motif of TSEN2 and an interaction with the proximal minor groove of the helix. TSEN34 and TSEN54 define the 3’ splice site by holding the tRNA body in place. TSEN54 adapts a bipartite fold with a flexible central region required for CLP1 binding. PCH-associated mutations are located far from pre-tRNA binding interfaces explaining their negative impact on structural integrity of TSEN without abrogating its catalytic activity in vitro10. Our work defines the molecular framework of pre-tRNA recognition and cleavage by TSEN and provides a structural basis to better understand PCH in the future.
The SLC26 family of transporters maintains anion equilibria in all kingdoms of life. The family shares a 7 + 7 transmembrane segments inverted repeat architecture with the SLC4 and SLC23 families, but holds a regulatory STAS domain in addition. While the only experimental SLC26 structure is monomeric, SLC26 proteins form structural and functional dimers in the lipid membrane. Here we resolve the structure of an SLC26 dimer embedded in a lipid membrane and characterize its functional relevance by combining PELDOR/DEER distance measurements and biochemical studies with MD simulations and spin-label ensemble refinement. Our structural model reveals a unique interface different from the SLC4 and SLC23 families. The functionally relevant STAS domain is no prerequisite for dimerization. Characterization of heterodimers indicates that protomers in the dimer functionally interact. The combined structural and functional data define the framework for a mechanistic understanding of functional cooperativity in SLC26 dimers.